<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Genomics</journal-id><journal-id journal-id-type="iso-abbrev">Int J Genomics</journal-id><journal-id journal-id-type="publisher-id">IJG</journal-id><journal-title-group><journal-title>International Journal of Genomics</journal-title></journal-title-group><issn pub-type="ppub">2314-436X</issn><issn pub-type="epub">2314-4378</issn><publisher><publisher-name>Hindawi Publishing Corporation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4121153</article-id><article-id pub-id-type="doi">10.1155/2014/837365</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Comparative Analysis of Glycogene Expression in Different Mouse Tissues Using RNA-Seq Data</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3395-8015</contrib-id><name><surname>Firoz</surname><given-names>Ahmad</given-names></name><xref ref-type="aff" rid="I1"><sup>1</sup>
</xref><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3453-6001</contrib-id><name><surname>Malik</surname><given-names>Adeel</given-names></name><xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref><xref ref-type="corresp" rid="cor2">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5935-3829</contrib-id><name><surname>Singh</surname><given-names>Sanjay Kumar</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref><xref ref-type="aff" rid="I4">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8015-9470</contrib-id><name><surname>Jha</surname><given-names>Vivekanand</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref><xref ref-type="aff" rid="I5">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ali</surname><given-names>Amjad</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="I1"><sup>1</sup>School of Chemistry and Biochemistry, Thapar University, Patiala, Punjab 147004, India</aff><aff id="I2"><sup>2</sup>Biomedical Informatics Center of ICMR, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh 160012, India</aff><aff id="I3"><sup>3</sup>School of Biotechnology, Yeungnam University, 280 Daehak-ro, Gyeongsan, Gyeongbuk 712-749, Republic of Korea</aff><aff id="I4"><sup>4</sup>Department of Biotechnology, Thapar University, Patiala, Punjab 147004, India</aff><aff id="I5"><sup>5</sup>Department of Nephrology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh 160012, India</aff><author-notes><corresp id="cor1">*Ahmad Firoz: <email>ahmadfirozbin@gmail.com</email> and </corresp><corresp id="cor2">*Adeel Malik: <email>adeel@procarb.org</email></corresp><fn fn-type="other"><p>Academic Editor: Giulia Piaggio</p></fn></author-notes><pub-date pub-type="ppub"><year>2014</year></pub-date><pub-date pub-type="epub"><day>9</day><month>7</month><year>2014</year></pub-date><volume>2014</volume><elocation-id>837365</elocation-id><history><date date-type="received"><day>13</day><month>5</month><year>2014</year></date><date date-type="accepted"><day>10</day><month>6</month><year>2014</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2014 Ahmad Firoz et al.</copyright-statement><copyright-year>2014</copyright-year><license license-type="open-access"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Glycogenes regulate a wide array of biological processes in the development of organisms as well as different diseases such as cancer, primary open-angle glaucoma, and renal dysfunction. The objective of this study was to explore the role of differentially expressed glycogenes (DEGGs) in three major tissues such as brain, muscle, and liver using mouse RNA-seq data, and we identified 579, 501, and 442 DEGGs for brain versus liver (BvL579), brain versus muscle (BvM501), and liver versus muscle (LvM442) groups. DAVID functional analysis suggested inflammatory response, glycosaminoglycan metabolic process, and protein maturation as the enriched biological processes in BvL579, BvM501, and LvM442, respectively. These DEGGs were then used to construct three interaction networks by using GeneMANIA, from which we detected potential hub genes such as <italic>PEMT</italic> and <italic>HPXN</italic> (BvL579), <italic>IGF2</italic> and <italic>NID2</italic> (BvM501), and <italic>STAT6</italic> and <italic>FLT1</italic> (LvM442), having the highest degree. Additionally, our community analysis results suggest that the significance of immune system related processes in liver, glycosphingolipid metabolic processes in the development of brain, and the processes such as cell proliferation, adhesion, and growth are important for muscle development. Further studies are required to confirm the role of predicted hub genes as well as the significance of biological processes.</p></abstract></article-meta></front><body><sec id="sec1"><title>1. Introduction</title><p>Cell function within an organism has huge variation due to gene expression pattern although all cells in an individual mammal have almost identical DNA [<xref rid="B1" ref-type="bibr">1</xref>]. It is important to know how cells and tissues differ in gene expression which is regulated during developmental changes in different tissues, consequently affecting their biological functions. The pattern of glycogene expression is one of important factors that provide clues about many biological functions, developmental changes, and diseases in human, mouse, and tissues of other organisms [<xref rid="B2" ref-type="bibr">2</xref>&#x02013;<xref rid="B4" ref-type="bibr">4</xref>]. Glycogene is a gene that is responsible for the glycosylation of proteins, lipids, and proteoglycans and includes genes associated with the synthesis of glycans such as glycosyltransferase, sugar-nucleotide transporters, and sulfotransferases [<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B6" ref-type="bibr">6</xref>]. Similarly, the term glycogenome involves all genes that play a role in glycosylation and represents more than 600 genes in the mouse genome [<xref rid="B7" ref-type="bibr">7</xref>]. Glycosylation is one of the most common posttranslational modification reactions [<xref rid="B8" ref-type="bibr">8</xref>]. The glycogene expression is relatively weak as compared to other molecules; however, different glycogenes are upregulated by specific tissues depending on the local conditions [<xref rid="B5" ref-type="bibr">5</xref>].</p><p>In order to understand the pathology of various diseases, recently, many studies have targeted and explored the role of glycogenes expression in various diseases [<xref rid="B9" ref-type="bibr">9</xref>&#x02013;<xref rid="B12" ref-type="bibr">12</xref>]. Alteration in the glycogene expression is also associated with drug resistance of various types of cancers including pancreatic cancer epithelial-mesenchymal transition [<xref rid="B13" ref-type="bibr">13</xref>], breast cancer [<xref rid="B14" ref-type="bibr">14</xref>], and hepatocarcinoma [<xref rid="B15" ref-type="bibr">15</xref>]. The change in the glycogene expression is also associated with conjunctival epithelium [<xref rid="B2" ref-type="bibr">2</xref>] and primary open-angle glaucoma (POAG) [<xref rid="B16" ref-type="bibr">16</xref>]. Moreover, the defects in the normal expression of glycogenes in tonsillar B lymphocytes are also correlated with the proteinuria and renal dysfunction in IgA nephropathy [<xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B18" ref-type="bibr">18</xref>].</p><p>Several high-throughput microarray studies have been applied to investigate the functional roles of various glycogenes [<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B19" ref-type="bibr">19</xref>, <xref rid="B20" ref-type="bibr">20</xref>]. However, to the best of our knowledge, no study till date has utilized RNA-Seq data in the existing databases to specifically explore the role of glycogenes. Previously, we identified the role of glycogenes in skeletal muscle development in MYOG<sub>kd</sub> cells by using RNA-Seq data. Therefore, in this work, we intend to investigate the role of glycogenes in various biological processes that are involved in the development of brain, muscle, and liver tissues using the precomputed expression values from mouse RNA-seq data. Functional and pathway analysis of differentially expressed glycogenes (DEGGs) between BvL579, BvM501, and LvM442 were enriched with gene ontology (GO) terms and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways, respectively. Additionally, the interaction networks of DEGGs were constructed to identify the hub genes as well as to detect the functional modules in these networks by using community analysis. We expect that the findings of our study may shed new lights on the roles of glycogenes in the development of these tissues and their pathogenesis.</p></sec><sec id="sec2"><title>2. Materials and Methods</title><sec id="sec2.1"><title>2.1. Datasets</title><p>The precomputed expression values with no spike for the brain, liver, and muscles C57BL6 mouse tissues were downloaded from WoldLab (<ext-link ext-link-type="uri" xlink:href="http://woldlab.caltech.edu/~alim/RNAseq/">http://woldlab.caltech.edu/~alim/RNAseq/</ext-link>) for our computational analysis. These precomputed expression values represent the RNA-seq analysis initially performed by Mortazavi et al., using Illumina Genome Analyzer and expression values computed by using ERANGE package [<xref rid="B21" ref-type="bibr">21</xref>]. To remove low expressed genes the dataset was filtered by removing genes with RPKM value &#x0003c;1 in all the three tissues.</p></sec><sec id="sec2.2"><title>2.2. Fold Change Analysis</title><p>Fold change is often used in analysis of gene expression data of RNAseq experiments, for measuring change in the expression level of a gene and comparing the expression of genes between two sets of arrays, for example, case and control sets. Fold change analysis of genes commonly expressed between two different samples was done to compare the gene expression in glycogenes [<xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B23" ref-type="bibr">23</xref>]. Fold change was calculated as the ratio of brain versus liver, brain versus muscle, and liver versus muscle groups. Additionally, to further investigate the role of glycogenes in different tissues, the differentially expressed genes were manually verified in the UniProt database [<xref rid="B24" ref-type="bibr">24</xref>] to check whether they represent a glycogene or not. A gene was considered as a glycogene if it was annotated as a &#x0201c;glycoprotein&#x0201d; in the &#x0201c;Keywords&#x0201d; section of the UniProt database.</p></sec><sec id="sec2.3"><title>2.3. Functional Analysis</title><p>DAVID (<ext-link ext-link-type="uri" xlink:href="http://david.abcc.ncifcrf.gov/home.jsp">http://david.abcc.ncifcrf.gov/home.jsp</ext-link>) functional annotation cluster analysis was performed on the list of differentially expressed glycogenes (DEGGs) with a fold change of &#x02265;2. Only those terms that reported a <italic>P</italic> value of &#x02264;0.05 and count number &#x02265;5 genes were selected for analysis. The gene ontology (GO) term biological process (BP) in DAVID was used to categorize enriched biological themes in the list of DEGGs. Pathway mapping was performed using the KEGG Automatic Annotation Server (KAAS) (<ext-link ext-link-type="uri" xlink:href="http://www.genome.jp/kegg/kaas/">http://www.genome.jp/kegg/kaas/</ext-link>) [<xref rid="B25" ref-type="bibr">25</xref>]. The amino acid sequences of these DEGGs were uploaded to the KAAS web server as an input using single-directional best hit (SBH) method to assign orthologs. KAAS offers functional annotation of genes in a genome via a BLAST similarity searches against a manually curated set of ortholog groups in the KEGG GENES database. KAAS assigned a KEGG orthology (KO) number to genes in the data sets, which were mapped to one of KEGG's reference pathways.</p></sec><sec id="sec2.4"><title>2.4. Network Analysis</title><p>The functional interactions between DEGGs were analyzed by GeneMANIA webserver [<xref rid="B26" ref-type="bibr">26</xref>]. The GO term biological process was used to create the interaction network between the DEGGs and 50 additional genes by using mouse as a source species. The relationship between the genes in the network includes coexpression, physical and genetic interactions, pathways, colocalization, protein domain similarity, and predicted interactions. The network was filtered by removing all the interactions where weights &#x0003c;0.1.</p></sec><sec id="sec2.5"><title>2.5. Identification of Hub Genes</title><p>Generally, the biological networks exhibit the scale-free property [<xref rid="B27" ref-type="bibr">27</xref>] where only a few nodes in the network have many connections that represent hubs in the network. Hub genes were identified by calculating the node degree distribution [<xref rid="B28" ref-type="bibr">28</xref>] by using the NetworkAnalyzer plugin of Cytoscape. A glycogene with the highest degree distribution was considered as a hub in the current network.</p></sec><sec id="sec2.6"><title>2.6. Community Analysis</title><p>The functional modules within the network were further detected by using the greedy community-structure detection algorithm, implemented in the Cytoscape plugin GLay (<ext-link ext-link-type="uri" xlink:href="http://brainarray.mbni.med.umich.edu/sugang/glay/">http://brainarray.mbni.med.umich.edu/sugang/glay/</ext-link>) [<xref rid="B29" ref-type="bibr">29</xref>]. GLay offers Cytoscape users a diverse group of community structure algorithms and graph layout functions for network clustering and structured visualization [<xref rid="B29" ref-type="bibr">29</xref>]. To identify the overrepresented biological functions within each cluster, the detected clusters were subjected to functional enrichment analyses by DAVID functional analysis tool. For enrichment analysis, only those communities were analyzed which have at least 10 nodes.</p></sec></sec><sec id="sec3"><title>3. Results</title><sec id="sec3.1"><title>3.1. Identification of Differentially Expressed Glycogenes (DEGGs)</title><p>We downloaded the precomputed RPKM values for mouse transcriptome that was mapped and quantified previously by RNA-Seq analysis [<xref rid="B21" ref-type="bibr">21</xref>]. This RNA-Seq data consists of RNA from adult mouse brain, liver, and skeletal muscle tissues and represents 33598 genes in each tissue sample. The data was further filtered by excluding the genes with RPKM values &#x0003c;1 from the analysis. As a result, 15,237, 11,920, and 12,202 genes were identified from brain, liver, and muscle samples, respectively (<xref ref-type="table" rid="tab1">Table 1(a)</xref>). Then three groups (brain versus liver, brain versus muscle, and liver versus muscle) were created and the number of genes that were common in each group were identified and summarized in <xref ref-type="table" rid="tab1">Table 1(b)</xref>. From the table, it can be observed that the number of common genes between brain versus liver is 10653, brain versus muscle is 10820, and liver versus muscle is 9833, respectively. These shared genes in each group were then used to calculate the fold change, which was defined as the ratio of RPKM values of brain versus liver, brain versus muscle, and liver versus muscle groups. In this study, the total fold change of &#x02265;2 was considered to classify the differentially expressed genes (DEGs). Based on this definition, there are 5228&#x02009;DEGs between brain versus liver, 5283 between brain versus muscle, and 3840 between liver versus muscle. The list of DEGs in each group was further filtered by retaining only those genes that were annotated as a &#x0201c;glycoprotein&#x0201d; in the UniProt database. Therefore, 579, 501, and 442 differentially expressed glycogenes (DEGGs) for brain versus liver (BvL579), brain versus muscle (BvM501), and liver versus muscle (LvM442) groups were selected for the final analysis (<xref ref-type="table" rid="tab1">Table 1(b)</xref>). The complete workflow of the analysis is shown in <xref ref-type="fig" rid="fig1">Figure 1</xref>.</p></sec><sec id="sec3.2"><title>3.2. Functional Annotation and Pathway Analysis</title><p>To classify biological processes that are enriched in the BvL579, BvM5, Annotation Cluster (FAC) tool available in the Database for Annotation, Visualization, and Integrated Discovery (DAVID) (<ext-link ext-link-type="uri" xlink:href="http://david.abcc.ncifcrf.gov/home.jsp">http://david.abcc.ncifcrf.gov/home.jsp</ext-link>). The GO term &#x0201c;Biological Process&#x0201d; was used for annotations, and top 10 GO terms having statistically significant <italic>P</italic> values from the resulting functional analysis for each group are listed in <xref ref-type="table" rid="tab2">Table 2</xref>. From this table, it can be seen that the GO terms that are enriched in BvL579 glycogenes represent functions necessary for response to wounding, inflammatory response, and blood coagulation (<xref ref-type="table" rid="tab2">Table 2(a)</xref>). The enriched GO terms in BvM501 include functions related to various metabolic (glycoprotein, glycosaminoglycan, sphingolipid, etc.) processes (<xref ref-type="table" rid="tab2">Table 2(b)</xref>). Similarly, functions related to protein maturation, inflammatory response, and complement activation are enriched in LvM442 samples (<xref ref-type="table" rid="tab2">Table 2(c)</xref>).</p><p>In addition to DAVID functional analysis, we also identified the biological pathways of BvL579, BvM501, and LvM442 DEGGs annotated in the present study. FASTA formatted amino acid sequences of DEGGs in these three sets were fed into the KAAS for prediction of distinct pathways. A total of 210 pathways were predicted for BvL579, whereas 193 and 198 pathways were predicted for BvM501 and LvM442, respectively. The top 10 KEGG pathways for each of the three categories are shown in <xref ref-type="table" rid="tab3">Table 3</xref> and a complete list of all pathways is provided in Supplementary Table S1 (Supplementary Material is available online at <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1155/2014/837365">http://dx.doi.org/10.1155/2014/837365</ext-link>). From these tables, it can be observed that the majority of the DEGGs were found to be associated with important biological processes, many being classified in signaling (e.g., PI3K-Akt and Rap1 signaling) pathways, cytokine-cytokine receptor interaction, or ECM-receptor interaction or being involved in adhesion related functions.</p></sec><sec id="sec3.3"><title>3.3. Interaction Network Construction and Identification of Hub Genes</title><p>DEGGs were mapped to the GeneMANIA to investigate how these genes interact with each other and additional genes that are related to a set of query genes by using a very large set of functional interaction data [<xref rid="B30" ref-type="bibr">30</xref>]. The genes showing significant interactions with weights higher than 0.1 were selected only for the network analysis. By integrating these relationships, a network between DEGGs and additional related genes was constructed for all the three groups, namely, BvL579, BvM501, and LvM442 (<xref ref-type="fig" rid="fig2">Figure 2</xref>). A GeneMANIA network analysis for interactions among the glycogene products suggested enrichment of GO terms related to positive regulation of locomotion, cell motility, and migration for BvL579 (<xref ref-type="table" rid="tab4">Table 4(a)</xref>), as well as LvM442 samples (<xref ref-type="table" rid="tab4">Table 4(c)</xref>). On the contrary, the processes related to extracellular matrix were overrepresented in BvM501 samples (<xref ref-type="table" rid="tab4">Table 4(b)</xref>).</p><p>The three interaction networks created from GeneMANIA were then exported to Cytoscape 2.8.2, a bioinformatics package for biological network visualization and data integration [<xref rid="B31" ref-type="bibr">31</xref>]. The initial network for BvL579 consists of 395 nodes and 1149 edges which were further filtered to 395 nodes and 1109 edges by removing duplicate edges (<xref ref-type="fig" rid="fig2">Figure 2(a)</xref>). In case of BvM501, the initial network consists of 352 nodes and 794 edges, whereas the filtered network has 352 nodes and 748 edges (<xref ref-type="fig" rid="fig2">Figure 2(b)</xref>). Similarly, the initial network for LvM442 network has 307 nodes and 695 edges, while the final network is represented by 307 nodes and 653 edges (<xref ref-type="fig" rid="fig2">Figure 2(c)</xref>). All the genes in the network are represented by circles and the interactions between them are represented as edges. Additionally, each query gene is shown in red whereas the additional related genes predicted by GeneMANIA are shown in cyan (<xref ref-type="fig" rid="fig2">Figure 2</xref>).</p><p>The node degree was then calculated for all the nodes in each network by using Network Analyzer plugin of Cytoscape. The higher the node degree, the more important the gene was, and the gene was denoted as a hub gene. The genes with highest node degree include<italic> PEMT</italic> (BvL579) and<italic> IGf2</italic> (BvM501), having node degree of 29 and 14, respectively. Both<italic> PEMT</italic> and<italic> IGF2</italic> were predicted by GeneMANIA as related genes in their respective networks and do not represent the glycogenes. However, the genes with second highest node degrees of 23 and 13 are represented by glycogenes<italic> HPXN</italic> and<italic> NID2</italic> in BvL579 and BvM501 networks (Figures <xref ref-type="fig" rid="fig3">3(a)</xref> and <xref ref-type="fig" rid="fig3">3(b)</xref>). Additionally,<italic> NID2</italic> was also predicted by GeneMANIA as a related gene in BvM501 network because it was removed from the query list as it showed a fold change of less than 2 in our analysis. In LvM442 network, the top node degree genes are<italic> STAT6</italic>, and the glycogene<italic> FLT1 </italic>(<xref ref-type="fig" rid="fig3">Figure 3(c)</xref>), both having the node degree of 13.</p></sec><sec id="sec3.4"><title>3.4. Community Analysis and Functional Annotation of the Detected Modules</title><p>In order to identify the biologically related genes in the three networks, we employed Fast Greedy community-structure identification algorithm, implemented in the Cytoscape plugin GLay (<ext-link ext-link-type="uri" xlink:href="http://brainarray.mbni.med.umich.edu/sugang/glay/">http://brainarray.mbni.med.umich.edu/sugang/glay/</ext-link>) [<xref rid="B29" ref-type="bibr">29</xref>] to identify functional modules, 31 (<xref ref-type="fig" rid="fig4">Figure 4(a)</xref>), 40 (<xref ref-type="fig" rid="fig4">Figure 4(b)</xref>), and 31 (<xref ref-type="fig" rid="fig4">Figure 4(c)</xref>) clusters were detected for BvL579, BvM501, and LvM442 networks, respectively. However, only those communities were selected for enrichment analyses which have at least 10 nodes. Therefore, based on this criterion, 8, 9, and 8 communities for BvL579, BvM501, and LvM442 networks were finally analyzed for overrepresentation of GO terms.</p><p>To biologically categorize these clusters, DAVID functional analysis tool was used to classify the genes in each module and observed the enrichment of GO term &#x0201c;Biological Process&#x0201d; in all the selected modules. The enrichment analysis for the modules for three networks is described as follows.</p><p>
<italic>BvL579.</italic> The top 10 statistically significant enriched GO terms for DEGGs in all 8 clusters for BvL579 community analysis are summarized in <xref ref-type="table" rid="tab5">Table 5(a)</xref>. The most statistically significant GO terms that were enriched in cluster 1 were related to immune response, complement activation, and protein maturation. Clusters 2, 3, and 7 show enrichment for GO terms response to wounding, blood coagulation, and hemostasis. Clusters 2 and 3 also show overrepresentation of terms such as blood vessel development and vasculature development. The GO terms of cluster 4 were mostly related to hair cycle, development of epidermis, and ectoderm. The GO functions of cluster 5 were most related to localization, motility and migration of cells, and regulation of cell proliferation. Cluster 6 was significantly enriched with functions related to homeostasis, transport, and metabolism of cholesterol, and lipid as well as sterol. Cluster 8 showed overrepresentation of functional terms related to the metabolism of glycosphingolipid, glycolipid, sphingolipid, and ganglioside.</p><p>
<italic>BvM501.</italic> The top 10 statistically significant enriched GO terms for DEGGs in all 9 clusters for BvM501 community analysis are summarized in (<xref ref-type="table" rid="tab5">Table 5(b)</xref>). Cluster 1 of this network shows overrepresentation of functions related to regulation of cell growth, protein maturation, and immune response. Cluster 2 is enriched in GO terms related to proteoglycan metabolic process as well as the development of blood vessel and vasculature. Cluster 3 is enriched in the functions related to the development of bone, cartilage, and skeletal system. The GO terms that are overrepresented in cluster 4 show enrichment for functions related to adhesion, such as biological adhesion, cell adhesion, cell-substrate adhesion, and cell-matrix adhesion. The processes related to localization, motility, and migration of cells are also overrepresented in cluster 4. Cluster 5 showed overrepresentation of functional terms related to the metabolism of glycosphingolipid, glycolipid, sphingolipid, and ganglioside. Additionally, the functions related to the metabolism of lipid and oligosaccharides are also enriched in this group. In cluster 6, functions related to homeostasis, remodelling, and regulation of transport are overrepresented. Response to hypoxia and oxygen levels, apoptosis, and metabolic processes such as phospholipid and organophosphate metabolic process are enriched in cluster 7. Similar to cluster 4, the GO terms that are overrepresented in Cluster 9 show enrichment for functions related to biological adhesion. Protein folding and metal ion transport are the other important enriched functions present in this cluster. Cluster 8 did not yield the enrichment of any statistically significant GO category.</p><p>
<italic>LvM442.</italic>
<xref ref-type="table" rid="tab5">Table 5(c)</xref> summarizes the top 10 statistically significant enriched GO terms for DEGGs in all 8 clusters for LvM442 community analysis. The GO terms related to development and morphogenesis of blood vessels, vasculature, and tube are enriched in cluster 1. Cluster 2 shows enrichment of functions related to various types of responses, such as response to wounding, external stimulus, and defense as well as inflammatory response. Other enriched functional groups in this cluster are regulation of cell growth, proliferation, and cell activation. One of the overrepresented functional groups in cluster 3 shows enrichment for functions related to biological adhesion, lipid catabolic process, and 4-hydroxyproline metabolic process. Cluster 4 represents the enrichment of functions related to protein folding and bone remodeling and resorption. Cluster 5 shows overrepresentation of GO terms such as regulation of T cell mediated cytotoxicity or immunity, regulation of leukocyte mediated cytotoxicity, and regulation of cell killing. Clusters 6 and 7 are enriched in functions related to immune or inflammatory response and complement activation. Finally, cluster 8 exhibited overrepresentation of signaling pathways such as hepatocyte growth factor receptor signaling and mesenchymal-epithelial cell signaling, in addition to processes concerning MAP kinase activity.</p></sec></sec><sec id="sec4"><title>4. Discussion</title><p>The current study offers the first thorough insight into the glycogene analysis of brain, muscle, and liver tissues from mouse RNA-Seq data. Understanding the structure and function of these glycogenes is essential for studying the development of various tissues as well as their functional roles. Most of the serum glycoproteins originates from liver suggesting that liver diseases associated with aberrant glycosylation can be reflected by the changes in serum glycoproteins [<xref rid="B32" ref-type="bibr">32</xref>]. Recently, the significance of glycomics of central nervous system (CNS) to identify potential glycobiomarkers in neurological diseases [<xref rid="B33" ref-type="bibr">33</xref>] and alterations in brain glycoproteins resulting from the aging process was shown [<xref rid="B34" ref-type="bibr">34</xref>]. Recent studies in the glycomics field also offered insights into the biological significance of the glycome in the pathogenesis of diseases in humans [<xref rid="B32" ref-type="bibr">32</xref>]. Additionally, many studies have highlighted the significance of glycoconjugates during skeletal muscle development [<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B23" ref-type="bibr">23</xref>, <xref rid="B35" ref-type="bibr">35</xref>].</p><p>With the evolution of bioinformatics during the past decades, molecular target discovery and targeted therapeutics have become a critical remedial treatment for diseases [<xref rid="B36" ref-type="bibr">36</xref>]. In this work, we screened DEGGs between brain, muscle, and liver tissues using RNA-Seq data and performed functional and pathway enrichment analysis using DAVID and KEGG tools. The most significant enriched GO terms for BvL579 are processes related to response to wounding or inflammatory response. These processes are represented by genes that play a prominent roles in innate immunity such as<italic> Mannan-binding lectin serine protease 1</italic> (<italic>MASP1</italic>),<italic> Mannan-binding lectin serine protease 2</italic> (<italic>MASP2</italic>),<italic> Mannose-binding protein A</italic> (<italic>MBL1</italic>), and<italic> Mannose-binding protein C</italic> (<italic>MBL2</italic>) [<xref rid="B37" ref-type="bibr">37</xref>, <xref rid="B38" ref-type="bibr">38</xref>]. BvM501 is enriched in functions related to glycoprotein metabolic processes and includes genes that code for various transferases such as N-acetylglucosamine-1-phosphotransferase subunit gamma (GNPTG) [<xref rid="B39" ref-type="bibr">39</xref>], Beta-galactoside alpha-2,6-sialyltransferase 1 (ST6GAL1) [<xref rid="B40" ref-type="bibr">40</xref>], and Beta-1,3-galactosyltransferase 6 (B3GALT6) [<xref rid="B41" ref-type="bibr">41</xref>]. Similarly, the top statistically significant enriched processes in LvM442 are related to protein maturation or processing and are represented by genes such as<italic> Battenin</italic> (<italic>CLN3</italic>) and<italic> Methionine aminopeptidase 2</italic> (<italic>METAP2</italic>). The CLN3 protein is involved in the late endosomal/lysosomal membrane transport [<xref rid="B42" ref-type="bibr">42</xref>], whereas METAP2 protein catalyzes the hydrolytic cleavage of the N-terminal methionine from newly synthesized polypeptides [<xref rid="B43" ref-type="bibr">43</xref>].</p><p>Additionally, three interaction networks of DEGGs were constructed for BvL579, BvM501, and LvM442 samples, and node degrees of genes were calculated.<italic> HPXN</italic>,<italic> NID2</italic>, and<italic> FLT1 </italic>were the glycogenes with the highest degree in BvL579, BvM501, and LvM442 networks, respectively. However, these genes represent the second highest node degree in their respective networks as genes (<italic>PEMT</italic>,<italic> IGF2</italic>, and<italic> STAT6</italic>) with top node degree that do not code for glycoproteins.</p><p>HPXN (~60&#x02009;kDa glycoprotein) is mainly synthesized by liver cells [<xref rid="B44" ref-type="bibr">44</xref>], secreted to the plasma where it binds free heme or hemin and inhibits its role in free radical reactions [<xref rid="B45" ref-type="bibr">45</xref>]. HPXN is also reported to be expressed by the cells of immune systems, ganglionic and photoreceptor cells of the retina, cells of the peripheral nervous system, and the mesangial cells of kidney [<xref rid="B46" ref-type="bibr">46</xref>&#x02013;<xref rid="B48" ref-type="bibr">48</xref>]. Recently, it was shown that HPX protein is also present in various regions of mouse brain [<xref rid="B49" ref-type="bibr">49</xref>]. NID2 is homologous to another member of the nidogen family, NID1, and both are found in all basement membranes (BMs) [<xref rid="B50" ref-type="bibr">50</xref>]. Both nidogens have a similar distribution in various organs during development; however, in adult tissues nidogen-2 distribution becomes more confined [<xref rid="B51" ref-type="bibr">51</xref>&#x02013;<xref rid="B53" ref-type="bibr">53</xref>]. Additionally, these nidogens show a broad range of interacting partners including other BM proteins such as laminin, collagen IV, and perlecan [<xref rid="B51" ref-type="bibr">51</xref>, <xref rid="B53" ref-type="bibr">53</xref>&#x02013;<xref rid="B55" ref-type="bibr">55</xref>]. They are involved in various functions including the regulation of cell attachment [<xref rid="B56" ref-type="bibr">56</xref>], neutrophil chemotaxis [<xref rid="B57" ref-type="bibr">57</xref>], trophoblast outgrowth [<xref rid="B58" ref-type="bibr">58</xref>], angiogenesis [<xref rid="B59" ref-type="bibr">59</xref>], osteoblast, and myogenic differentiation [<xref rid="B60" ref-type="bibr">60</xref>, <xref rid="B61" ref-type="bibr">61</xref>]. Vascular endothelial growth factors (VEGFs) constitute a family of six polypeptides (VEGF-A, -B, -C, -D, -E, and PlGF) that regulate blood and lymphatic vessel development [<xref rid="B62" ref-type="bibr">62</xref>]. VEGF signaling occurs by binding to various cellular receptors such as VEGFR1 (FLT1), VEGFR2 (FLK1), and VEGFR3 (FLT4) [<xref rid="B63" ref-type="bibr">63</xref>, <xref rid="B64" ref-type="bibr">64</xref>] and neuropilin-1 [<xref rid="B65" ref-type="bibr">65</xref>] and -2 (NRP1 and NRP2) [<xref rid="B66" ref-type="bibr">66</xref>] and heparan sulfate proteoglycans (HSPG) [<xref rid="B67" ref-type="bibr">67</xref>]. FLT1 and FLK1 are closely related receptor tyrosine kinases and both share common and specific ligands [<xref rid="B68" ref-type="bibr">68</xref>]. FLT1 has weaker kinase activity than FLK1 [<xref rid="B68" ref-type="bibr">68</xref>]; however, FLT1 is essential for normal development and angiogenesis as reported in previous FLT1 null mutant mice studies [<xref rid="B69" ref-type="bibr">69</xref>&#x02013;<xref rid="B71" ref-type="bibr">71</xref>].</p><p>Recognizing the structure and function of biological networks is indispensable for the investigation of biological processes. In this work, we identified 8, 9, and 8 functional modules or communities for BvL579, BvM501, and LvM442 networks using fast greedy algorithm implemented as GLAY [<xref rid="B29" ref-type="bibr">29</xref>], plugin for cytoscape. Furthermore, the function of each module in all the three networks was explored by using functional annotation tool DAVID. Our analysis shows that the modules that are common in BvL579 and LvM442 networks show enrichment for processes related to immune and inflammatory response and response to wounding. Liver is known to play an important role in innate immunity, an important primary line of defense against infection [<xref rid="B72" ref-type="bibr">72</xref>]. Additionally, Kupffer cells in the liver are one of the earliest to be affected by bacterial or sterile insults and add to the inflammatory response [<xref rid="B73" ref-type="bibr">73</xref>]. This sterile inflammation can be responsible for liver injury; it may also play a role in liver repair [<xref rid="B72" ref-type="bibr">72</xref>]. In case of the modules of BvM501 and LvM442 networks, the enrichment of processes related to cell adhesion, proliferation, and regulation of cell growth is observed. The expression of myogenic regulatory factors (MRFs) describes the different stages of skeletal muscle development that includes myoblast proliferation, cell-cycle exit, cell fusion, and the maturation of myotubes to form myofibers [<xref rid="B23" ref-type="bibr">23</xref>]. Cell adhesion molecules such as cadherins are glycoproteins that mediate homotypic cell-cell adhesion through their extracellular domain [<xref rid="B74" ref-type="bibr">74</xref>], and this cadherin-dependent adhesion is necessary for diverse types of cellular functions [<xref rid="B75" ref-type="bibr">75</xref>]. Finally, glycosphingolipid or glycolipid metabolic processes show overrepresentation in modules of BvL579 and BvM501 networks. Glycosphingolipids are universally expressed in all vertebrate cells as well as body fluids, but they are richer in the nervous system [<xref rid="B76" ref-type="bibr">76</xref>]. Previous studies have established the role of glycosphingolipids in the development of the brain among various species [<xref rid="B77" ref-type="bibr">77</xref>, <xref rid="B78" ref-type="bibr">78</xref>].</p></sec><sec id="sec5"><title>5. Conclusion</title><p>Overall, in this work we have used a systems biology approach to identify the DEGGs, their functional enrichment, and identified potential hub genes by constructing three glycogene interaction networks. We also identified functional modules in these networks and indicate the significance of immune system related processes in liver, and glycosphingolipid metabolic processes in the development of brain. Similarly, we observe that the processes such as cell proliferation, adhesion, and growth are important for muscle development. The findings deduced from the current work are in consistence with the previous studies. Experimental validation will be required to confirm the predictions made in this study that will establish the role of predicted hubs as well as enriched functional processes in these tissues.</p></sec><sec sec-type="supplementary-material" id="supplementary-material-sec"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="f1"><caption><p>Supplementary Table S1: List of all KEGG pathways reported for different tissue groups. Each sheet contains the list of KEGG pathways and the number of mapped genes in brain versus liver (BvL579), brain versus muscle (BvM501), and liver versus muscle (LvM442) groups.</p></caption><media xlink:href="837365.f1.pdf" mimetype="application" mime-subtype="pdf" orientation="portrait" id="d35e780" position="anchor"/></supplementary-material></sec></body><back><ack><title>Acknowledgments</title><p>Authors would like to acknowledge the support from the Biomedical Informatics Center of ICMR, PGIMER (Chandigarh, India); School of Chemistry and Biochemistry, Thapar University, (Patiala, India); and School of Biotechnology, Yeungnam University (Gyeongsan, South Korea) for providing lab facilities to conduct this research.</p></ack><sec sec-type="conflict"><title>Conflict of Interests</title><p>The authors declare that there is no conflict of interests regarding the publication of this paper.</p></sec><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salzman</surname><given-names>J</given-names></name><name><surname>Jiang</surname><given-names>H</given-names></name><name><surname>Wong</surname><given-names>WH</given-names></name></person-group><article-title>Statistical modeling of RNA-Seq data</article-title><source><italic>Statistical Science</italic></source><year>2011</year><volume>26</volume><issue>1</issue><fpage>62</fpage><lpage>83</lpage><pub-id pub-id-type="other">MR2849910</pub-id><pub-id pub-id-type="other">2-s2.0-80053314092</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mantelli</surname><given-names>F</given-names></name><name><surname>Schaffer</surname><given-names>L</given-names></name><name><surname>Dana</surname><given-names>R</given-names></name><name><surname>Head</surname><given-names>SR</given-names></name><name><surname>Arg&#x000fc;eso</surname><given-names>P</given-names></name></person-group><article-title>Glycogene expression in conjunctiva of patients with dry eye: downregulation of Notch signaling</article-title><source><italic>PLoS ONE</italic></source><year>2010</year><volume>50</volume><issue>6</issue><fpage>2666</fpage><lpage>2672</lpage></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishii</surname><given-names>A</given-names></name><name><surname>Hitoshi</surname><given-names>S</given-names></name><name><surname>Fujimoto</surname><given-names>I</given-names></name><etal/></person-group><article-title>Developmental changes in the expression of glycogenes and the content of <italic>N</italic>-glycans in the mouse cerebral cortex</article-title><source><italic>Glycobiology</italic></source><year>2007</year><volume>17</volume><issue>3</issue><fpage>261</fpage><lpage>276</lpage><pub-id pub-id-type="other">2-s2.0-33847361011</pub-id><pub-id pub-id-type="pmid">17172259</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Nakayama</surname><given-names>Y</given-names></name><name><surname>Nakamura</surname><given-names>N</given-names></name><name><surname>Tsuji</surname><given-names>D</given-names></name><name><surname>Itoh</surname><given-names>K</given-names></name><name><surname>Kurosaka</surname><given-names>A</given-names></name></person-group><article-title>Genetic diseases associated with protein glycosylation disorders in mammals</article-title><source><italic>Genetic Disorders</italic></source><year>2013</year><publisher-name>InTechOpen</publisher-name></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="other"><comment><ext-link ext-link-type="uri" xlink:href="http://www.stelic.com/cn27/pg122.html">http://www.stelic.com/cn27/pg122.html</ext-link></comment></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Taniguchi</surname><given-names>N</given-names></name><name><surname>Suzuki</surname><given-names>A</given-names></name><name><surname>Ito</surname><given-names>Y</given-names></name><etal/></person-group><source><italic>Experimental Glycoscience: Glycobiology</italic></source><year>2009</year><publisher-loc>New York, NY, USA</publisher-loc><publisher-name>Springer</publisher-name></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janot</surname><given-names>M</given-names></name><name><surname>Audfray</surname><given-names>A</given-names></name><name><surname>Loriol</surname><given-names>C</given-names></name><name><surname>Germot</surname><given-names>A</given-names></name><name><surname>Maftah</surname><given-names>A</given-names></name><name><surname>Dupuy</surname><given-names>F</given-names></name></person-group><article-title>Glycogenome expression dynamics during mouse C2C12 myoblast differentiation suggests a sequential reorganization of membrane glycoconjugates</article-title><source><italic>BMC Genomics</italic></source><year>2009</year><volume>10</volume><issue>483</issue><pub-id pub-id-type="other">2-s2.0-70549103311</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Hao</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Ma</surname><given-names>H</given-names></name><name><surname>Jia</surname><given-names>L</given-names></name></person-group><article-title>Modification of glycosylation mediates the invasive properties of murine hepatocarcinoma cell lines to lymph nodes</article-title><source><italic>PLoS ONE</italic></source><year>2013</year><volume>20</volume><issue>8</issue><pub-id pub-id-type="publisher-id">e65218</pub-id><pub-id pub-id-type="other">2-s2.0-84879263293</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ngamukote</surname><given-names>S</given-names></name><name><surname>Yanagisawa</surname><given-names>M</given-names></name><name><surname>Ariga</surname><given-names>T</given-names></name><name><surname>Ando</surname><given-names>S</given-names></name><name><surname>Yu</surname><given-names>RK</given-names></name></person-group><article-title>Developmental changes of glycosphingolipids and expression of glycogenes in mouse brains</article-title><source><italic>Journal of Neurochemistry</italic></source><year>2007</year><volume>103</volume><issue>6</issue><fpage>2327</fpage><lpage>2341</lpage><pub-id pub-id-type="other">2-s2.0-36448995805</pub-id><pub-id pub-id-type="pmid">17883393</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Urita</surname><given-names>A</given-names></name><name><surname>Matsuhashi</surname><given-names>T</given-names></name><name><surname>Onodera</surname><given-names>T</given-names></name><etal/></person-group><article-title>Alterations of high-mannose type N-glycosylation in human and mouse osteoarthritis cartilage</article-title><source><italic>Arthritis and Rheumatism</italic></source><year>2011</year><volume>63</volume><issue>11</issue><fpage>3428</fpage><lpage>3438</lpage><pub-id pub-id-type="other">2-s2.0-80155211493</pub-id><pub-id pub-id-type="pmid">21834068</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saravanan</surname><given-names>C</given-names></name><name><surname>Cao</surname><given-names>Z</given-names></name><name><surname>Head</surname><given-names>SR</given-names></name><name><surname>Panjwani</surname><given-names>N</given-names></name></person-group><article-title>Analysis of differential expression of glycosyltransferases in healing corneas by glycogene microarrays</article-title><source><italic>Glycobiology</italic></source><year>2010</year><volume>20</volume><issue>1</issue><fpage>13</fpage><lpage>23</lpage><pub-id pub-id-type="other">2-s2.0-70849123863</pub-id><pub-id pub-id-type="pmid">19736239</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saravanan</surname><given-names>C</given-names></name><name><surname>Cao</surname><given-names>Z</given-names></name><name><surname>Head</surname><given-names>SR</given-names></name><name><surname>Panjwani</surname><given-names>N</given-names></name></person-group><article-title>Detection of differentially expressed wound-healing- related glycogenes in galectin-3-deficient mice</article-title><source><italic>Investigative Ophthalmology and Visual Science</italic></source><year>2009</year><volume>50</volume><issue>12</issue><fpage>5690</fpage><lpage>5696</lpage><pub-id pub-id-type="other">2-s2.0-73349131424</pub-id><pub-id pub-id-type="pmid">19643959</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maupin</surname><given-names>KA</given-names></name><name><surname>Sinha</surname><given-names>A</given-names></name><name><surname>Eugster</surname><given-names>E</given-names></name><etal/></person-group><article-title>Glycogene expression alterations associated with pancreatic cancer Epithelial-mesenchymal transition in complementary model systems</article-title><source><italic>PLoS ONE</italic></source><year>2010</year><volume>5</volume><issue>9</issue><pub-id pub-id-type="publisher-id">e13002</pub-id><pub-id pub-id-type="other">2-s2.0-77958516882</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>H</given-names></name><name><surname>Miao</surname><given-names>X</given-names></name><name><surname>Ma</surname><given-names>Q</given-names></name><name><surname>Zheng</surname><given-names>W</given-names></name><name><surname>Zhou</surname><given-names>H</given-names></name><name><surname>Jia</surname><given-names>L</given-names></name></person-group><article-title>Functional roles of glycogene and N-glycan in multidrug resistance of human breast cancer cells</article-title><source><italic>IUBMB Life</italic></source><year>2013</year><volume>65</volume><issue>5</issue><fpage>409</fpage><lpage>422</lpage><pub-id pub-id-type="other">2-s2.0-84876944143</pub-id><pub-id pub-id-type="pmid">23441047</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>R</given-names></name><name><surname>Cheng</surname><given-names>L</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Glycogenes mediate the invasive properties and chemosensitivity of human hepatocarcinoma cells</article-title><source><italic>The International Journal of Biochemistry and Cell Biology</italic></source><year>2013</year><volume>45</volume><issue>2</issue><fpage>347</fpage><lpage>358</lpage><pub-id pub-id-type="other">2-s2.0-84872304068</pub-id><pub-id pub-id-type="pmid">23103836</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diskin</surname><given-names>S</given-names></name><name><surname>Kumar</surname><given-names>J</given-names></name><name><surname>Cao</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Detection of differentially expressed glycogenes in trabecular meshwork of eyes with primary open-angle glaucoma</article-title><source><italic>Investigative Ophthalmology and Visual Science</italic></source><year>2006</year><volume>47</volume><issue>4</issue><fpage>1491</fpage><lpage>1499</lpage><pub-id pub-id-type="other">2-s2.0-33645965305</pub-id><pub-id pub-id-type="pmid">16565384</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inoue</surname><given-names>T</given-names></name><name><surname>Sugiyama</surname><given-names>H</given-names></name><name><surname>Kitagawa</surname><given-names>M</given-names></name><etal/></person-group><article-title>Abnormalities of glycogenes in tonsillar lymphocytes in IgA nephropathy</article-title><source><italic>Advances in Otorhinolaryngology</italic></source><year>2011</year><volume>72</volume><fpage>71</fpage><lpage>74</lpage></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inoue</surname><given-names>T</given-names></name><name><surname>Sugiyama</surname><given-names>H</given-names></name><name><surname>Hiki</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Differential expression of glycogenes in tonsillar B lymphocytes in association with proteinuria and renal dysfunction in IgA nephropathy</article-title><source><italic>Clinical Immunology</italic></source><year>2010</year><volume>136</volume><issue>3</issue><fpage>447</fpage><lpage>455</lpage><pub-id pub-id-type="other">2-s2.0-77955281350</pub-id><pub-id pub-id-type="pmid">20538527</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kroes</surname><given-names>RA</given-names></name><name><surname>Dawson</surname><given-names>G</given-names></name><name><surname>Moskal</surname><given-names>JR</given-names></name></person-group><article-title>Focused microarray analysis of glyco-gene expression in human glioblastomas.</article-title><source><italic>Journal of neurochemistry</italic></source><year>2007</year><volume>103</volume><issue>supplement s1</issue><fpage>14</fpage><lpage>24</lpage><pub-id pub-id-type="other">2-s2.0-38449088811</pub-id><pub-id pub-id-type="pmid">17986135</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>Z</given-names></name><name><surname>Lu</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><etal/></person-group><article-title>Altered N-glycan expression profile in epithelial-to-mesenchymal transition of NMuMG cells revealed by an integrated strategy using mass spectrometry and glycogene and lectin microarray analysis</article-title><source><italic>Journal of Proteome Research</italic></source><year>2014</year><volume>13</volume><issue>6</issue><fpage>2783</fpage><lpage>2795</lpage><pub-id pub-id-type="pmid">24724545</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mortazavi</surname><given-names>A</given-names></name><name><surname>Williams</surname><given-names>BA</given-names></name><name><surname>McCue</surname><given-names>K</given-names></name><name><surname>Schaeffer</surname><given-names>L</given-names></name><name><surname>Wold</surname><given-names>B</given-names></name></person-group><article-title>Mapping and quantifying mammalian transcriptomes by RNA-Seq</article-title><source><italic>Nature Methods</italic></source><year>2008</year><volume>5</volume><issue>7</issue><fpage>621</fpage><lpage>628</lpage><pub-id pub-id-type="other">2-s2.0-46249106990</pub-id><pub-id pub-id-type="pmid">18516045</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Sheng</surname><given-names>Q</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Ye</surname><given-names>F</given-names></name><name><surname>Samuels</surname><given-names>DC</given-names></name><name><surname>Shyr</surname><given-names>Y</given-names></name></person-group><article-title>Large scale comparison of gene expression levels by microarrays and RNAseq using TCGA data</article-title><source><italic>PLoS ONE</italic></source><year>2013</year><volume>8</volume><issue>8</issue><pub-id pub-id-type="publisher-id">e71462</pub-id><pub-id pub-id-type="other">2-s2.0-84882692468</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>EJ</given-names></name><name><surname>Malik</surname><given-names>A</given-names></name><name><surname>Pokharel</surname><given-names>S</given-names></name><etal/></person-group><article-title>Identification of genes differentially expressed in <italic>myogenin</italic> knock-down bovine muscle satellite cells during differentiation through RNA sequencing analysis</article-title><source><italic>PLoS ONE</italic></source><year>2014</year><volume>9</volume><issue>3</issue><pub-id pub-id-type="publisher-id">e92447</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="other"><comment><ext-link ext-link-type="uri" xlink:href="http://www.uniprot.org/">http://www.uniprot.org/</ext-link></comment></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moriya</surname><given-names>Y</given-names></name><name><surname>Itoh</surname><given-names>M</given-names></name><name><surname>Okuda</surname><given-names>S</given-names></name><name><surname>Yoshizawa</surname><given-names>AC</given-names></name><name><surname>Kanehisa</surname><given-names>M</given-names></name></person-group><article-title>KAAS: an automatic genome annotation and pathway reconstruction server</article-title><source><italic>Nucleic Acids Research</italic></source><year>2007</year><volume>35</volume><issue>2, supplement</issue><fpage>W182</fpage><lpage>W185</lpage><pub-id pub-id-type="other">2-s2.0-34547588704</pub-id><pub-id pub-id-type="pmid">17526522</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montojo</surname><given-names>J</given-names></name><name><surname>Zuberi</surname><given-names>K</given-names></name><name><surname>Rodriguez</surname><given-names>H</given-names></name><etal/></person-group><article-title>GeneMANIA cytoscape plugin: fast gene function predictions on the desktop</article-title><source><italic>Bioinformatics</italic></source><year>2010</year><volume>26</volume><issue>22</issue><fpage>2927</fpage><lpage>2928</lpage><pub-id pub-id-type="publisher-id">btq562</pub-id><pub-id pub-id-type="other">2-s2.0-78149262301</pub-id><pub-id pub-id-type="pmid">20926419</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albert</surname><given-names>R</given-names></name></person-group><article-title>Scale-free networks in cell biology</article-title><source><italic>Journal of Cell Science</italic></source><year>2005</year><volume>118</volume><issue>21</issue><fpage>4947</fpage><lpage>4957</lpage><pub-id pub-id-type="other">2-s2.0-27944493925</pub-id><pub-id pub-id-type="pmid">16254242</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>XR</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name></person-group><article-title>Analyzing protein interaction networks via random graph model</article-title><source><italic>International Journal of Information Technology</italic></source><year>2005</year><volume>11</volume><fpage>125</fpage><lpage>132</lpage></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>G</given-names></name><name><surname>Kuchinsky</surname><given-names>A</given-names></name><name><surname>Morris</surname><given-names>JH</given-names></name><name><surname>States</surname><given-names>DJ</given-names></name><name><surname>Meng</surname><given-names>F</given-names></name></person-group><article-title>GLay: community structure analysis of biological networks</article-title><source><italic>Bioinformatics</italic></source><year>2010</year><volume>26</volume><issue>24</issue><fpage>3135</fpage><lpage>3137</lpage><pub-id pub-id-type="other">2-s2.0-79951764932</pub-id><pub-id pub-id-type="pmid">21123224</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farley</surname><given-names>DW</given-names></name><name><surname>Donaldson</surname><given-names>SL</given-names></name><name><surname>Comes</surname><given-names>O</given-names></name><etal/></person-group><article-title>The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function</article-title><source><italic>Nucleic Acids Research</italic></source><year>2010</year><volume>38</volume><issue>2</issue><fpage>W214</fpage><lpage>W220</lpage><pub-id pub-id-type="other">2-s2.0-77954269901</pub-id><pub-id pub-id-type="pmid">20576703</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smoot</surname><given-names>ME</given-names></name><name><surname>Ono</surname><given-names>K</given-names></name><name><surname>Ruscheinski</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name><name><surname>Ideker</surname><given-names>T</given-names></name></person-group><article-title>Cytoscape 2.8: new features for data integration and network visualization</article-title><source><italic>Bioinformatics</italic></source><year>2011</year><volume>27</volume><issue>3</issue><fpage>431</fpage><lpage>432</lpage><pub-id pub-id-type="other">2-s2.0-79551587720</pub-id><pub-id pub-id-type="pmid">21149340</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adamczyk</surname><given-names>B</given-names></name><name><surname>Tharmalingam</surname><given-names>T</given-names></name><name><surname>Rudd</surname><given-names>PM</given-names></name></person-group><article-title>Glycans as cancer biomarkers</article-title><source><italic>Biochimica et Biophysica Acta&#x02014;General Subjects</italic></source><year>2012</year><volume>1820</volume><issue>9</issue><fpage>1347</fpage><lpage>1353</lpage><pub-id pub-id-type="other">2-s2.0-84862840416</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barone</surname><given-names>R</given-names></name><name><surname>Sturiale</surname><given-names>L</given-names></name><name><surname>Palmigiano</surname><given-names>A</given-names></name><name><surname>Zappia</surname><given-names>M</given-names></name><name><surname>Garozzo</surname><given-names>D</given-names></name></person-group><article-title>Glycomics of pediatric and adulthood diseases of the central nervous system</article-title><source><italic>Journal of Proteomics</italic></source><year>2012</year><volume>75</volume><issue>17</issue><fpage>5123</fpage><lpage>5139</lpage><pub-id pub-id-type="other">2-s2.0-84865541699</pub-id><pub-id pub-id-type="pmid">22813883</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>Y</given-names></name><name><surname>Endo</surname><given-names>T</given-names></name></person-group><article-title>Alteration of brain glycoproteins during aging</article-title><source><italic>Geriatrics and Gerontology International</italic></source><year>2010</year><volume>10</volume><fpage>S32</fpage><lpage>S40</lpage><pub-id pub-id-type="other">2-s2.0-77954681104</pub-id><pub-id pub-id-type="pmid">20590840</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cornelison</surname><given-names>DDW</given-names></name><name><surname>Wilcox-Adelman</surname><given-names>SA</given-names></name><name><surname>Goetinck</surname><given-names>PF</given-names></name><name><surname>Rauvala</surname><given-names>H</given-names></name><name><surname>Rapraeger</surname><given-names>AC</given-names></name><name><surname>Olwin</surname><given-names>BB</given-names></name></person-group><article-title>Essential and separable roles for Syndecan-3 and Syndecan-4 in skeletal muscle development and regeneration</article-title><source><italic>Genes and Development</italic></source><year>2004</year><volume>18</volume><issue>18</issue><fpage>2231</fpage><lpage>2236</lpage><pub-id pub-id-type="other">2-s2.0-4444240885</pub-id><pub-id pub-id-type="pmid">15371336</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dinh</surname><given-names>P</given-names></name><name><surname>Sotiriou</surname><given-names>C</given-names></name><name><surname>Piccart</surname><given-names>MJ</given-names></name></person-group><article-title>The evolution of treatment strategies: aiming at the target</article-title><source><italic>Breast</italic></source><year>2007</year><volume>16</volume><issue>supplement 2</issue><fpage>10</fpage><lpage>16</lpage><pub-id pub-id-type="other">2-s2.0-35649021683</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nauta</surname><given-names>AJ</given-names></name><name><surname>Raashou-Jensen</surname><given-names>N</given-names></name><name><surname>Roos</surname><given-names>A</given-names></name><etal/></person-group><article-title>Mannose-binding lectin engagement with late apoptotic and necrotic cells</article-title><source><italic>European Journal of Immunology</italic></source><year>2003</year><volume>33</volume><issue>10</issue><fpage>2853</fpage><lpage>2863</lpage><pub-id pub-id-type="other">2-s2.0-0242335087</pub-id><pub-id pub-id-type="pmid">14515269</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>M&#x000f8;ller-Kristensen</surname><given-names>M</given-names></name><name><surname>Thiel</surname><given-names>S</given-names></name><name><surname>Sj&#x000f6;holm</surname><given-names>A</given-names></name><name><surname>Matsushita</surname><given-names>M</given-names></name><name><surname>Jensenius</surname><given-names>JC</given-names></name></person-group><article-title>Cooperation between MASP-1 and MASP-2 in the generation of C3 convertase through the MBL pathway</article-title><source><italic>International Immunology</italic></source><year>2007</year><volume>19</volume><issue>2</issue><fpage>141</fpage><lpage>149</lpage><pub-id pub-id-type="other">2-s2.0-33846618236</pub-id><pub-id pub-id-type="pmid">17182967</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qian</surname><given-names>Y</given-names></name><name><surname>Lee</surname><given-names>I</given-names></name><name><surname>Lee</surname><given-names>W</given-names></name><etal/></person-group><article-title>Functions of the <italic>&#x003b1;</italic>, <italic>&#x003b2;</italic>, and <italic>&#x003b3;</italic>subunits of UDP-GlcNAc:Lysosomal enzyme <italic>N</italic>-acetylglucosamine-1-phosphotransferase</article-title><source><italic>The Journal of Biological Chemistry</italic></source><year>2010</year><volume>285</volume><issue>5</issue><fpage>3360</fpage><lpage>3370</lpage><pub-id pub-id-type="other">2-s2.0-77449112978</pub-id><pub-id pub-id-type="pmid">19955174</pub-id></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuhn</surname><given-names>B</given-names></name><name><surname>Benz</surname><given-names>J</given-names></name><name><surname>Greif</surname><given-names>M</given-names></name><name><surname>Engel</surname><given-names>AM</given-names></name><name><surname>Sobek</surname><given-names>H</given-names></name><name><surname>Rudolph</surname><given-names>MG</given-names></name></person-group><article-title>The structure of human <italic>&#x003b1;</italic>-2, 6-sialyltransferase reveals the binding mode of complex glycans</article-title><source><italic>Acta Crystallographica D</italic></source><year>2013</year><volume>69</volume><fpage>1826</fpage><lpage>1838</lpage></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bai</surname><given-names>X</given-names></name><name><surname>Zhou</surname><given-names>D</given-names></name><name><surname>Brown</surname><given-names>JR</given-names></name><name><surname>Crawford</surname><given-names>BE</given-names></name><name><surname>Hennet</surname><given-names>T</given-names></name><name><surname>Esko</surname><given-names>JD</given-names></name></person-group><article-title>Biosynthesis of the linkage region of glycosaminoglycans: cloning and activity of galactosyltransferase II, the sixth member of the <italic>&#x003b2;</italic>1,3-galactosyltransferase family (<italic>&#x003b2;</italic>3GalT6)</article-title><source><italic>Journal of Biological Chemistry</italic></source><year>2001</year><volume>276</volume><issue>51</issue><fpage>48189</fpage><lpage>48195</lpage><pub-id pub-id-type="other">2-s2.0-0035930615</pub-id><pub-id pub-id-type="pmid">11551958</pub-id></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uusi-Rauva</surname><given-names>K</given-names></name><name><surname>Kytt&#x000e4;l&#x000e4;</surname><given-names>A</given-names></name><name><surname>Van Der Kant</surname><given-names>R</given-names></name><etal/></person-group><article-title>Neuronal ceroid lipofuscinosis protein CLN3 interacts with motor proteins and modifies location of late endosomal compartments</article-title><source><italic>Cellular and Molecular Life Sciences</italic></source><year>2012</year><volume>69</volume><issue>12</issue><fpage>2075</fpage><lpage>2089</lpage><pub-id pub-id-type="other">2-s2.0-84862838085</pub-id><pub-id pub-id-type="pmid">22261744</pub-id></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Nacev</surname><given-names>BA</given-names></name><name><surname>Liu</surname><given-names>JO</given-names></name><name><surname>Pei</surname><given-names>D</given-names></name></person-group><article-title>Protein N-terminal processing: substrate specificity of <italic>Escherichia coli</italic> and human methionine aminopeptidases</article-title><source><italic>Biochemistry</italic></source><year>2010</year><volume>49</volume><issue>26</issue><fpage>5588</fpage><lpage>5599</lpage><pub-id pub-id-type="other">2-s2.0-77954194681</pub-id><pub-id pub-id-type="pmid">20521764</pub-id></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen-Roetling</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Regan</surname><given-names>RF</given-names></name></person-group><article-title>Hemopexin decreases hemin accumulation and catabolism by neural cells</article-title><source><italic>Neurochemistry International</italic></source><year>2012</year><volume>60</volume><issue>5</issue><fpage>488</fpage><lpage>494</lpage><pub-id pub-id-type="other">2-s2.0-84862795593</pub-id><pub-id pub-id-type="pmid">22342655</pub-id></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tolosano</surname><given-names>E</given-names></name><name><surname>Fagoonee</surname><given-names>S</given-names></name><name><surname>Morello</surname><given-names>N</given-names></name><name><surname>Vinchi</surname><given-names>F</given-names></name><name><surname>Fiorito</surname><given-names>V</given-names></name></person-group><article-title>Heme scavenging and the other facets of hemopexin</article-title><source><italic>Antioxidants &#x00026; Redox Signaling</italic></source><year>2010</year><volume>12</volume><issue>2</issue><fpage>305</fpage><lpage>320</lpage><pub-id pub-id-type="other">2-s2.0-77949497609</pub-id><pub-id pub-id-type="pmid">19650691</pub-id></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Camborieux</surname><given-names>L</given-names></name><name><surname>Bertrand</surname><given-names>N</given-names></name><name><surname>Swerts</surname><given-names>JP</given-names></name></person-group><article-title>Changes in expression and localization of hemopexin and its transcripts in injured nervous system: a comparison of central and peripheral tissues</article-title><source><italic>Neuroscience</italic></source><year>1997</year><volume>82</volume><issue>4</issue><fpage>1039</fpage><lpage>1052</lpage><pub-id pub-id-type="other">2-s2.0-0343051937</pub-id><pub-id pub-id-type="pmid">9466428</pub-id></element-citation></ref><ref id="B47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hunt</surname><given-names>RC</given-names></name><name><surname>Hunt</surname><given-names>DM</given-names></name><name><surname>Gaur</surname><given-names>N</given-names></name><name><surname>Smith</surname><given-names>A</given-names></name></person-group><article-title>Hemopexin in the human retina: protection of the retina against heme-mediated toxicity</article-title><source><italic>Journal of Cellular Physiology</italic></source><year>1996</year><volume>168</volume><issue>1</issue><fpage>71</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">8647924</pub-id></element-citation></ref><ref id="B48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kapojos</surname><given-names>JJ</given-names></name><name><surname>van Den Berg</surname><given-names>A</given-names></name><name><surname>van Goor</surname><given-names>H</given-names></name><etal/></person-group><article-title>Production of hemopexin by TNF-<italic>&#x003b1;</italic> stimulated human mesangial cells</article-title><source><italic>Kidney International</italic></source><year>2003</year><volume>63</volume><issue>5</issue><fpage>1681</fpage><lpage>1686</lpage><pub-id pub-id-type="other">2-s2.0-0242669259</pub-id><pub-id pub-id-type="pmid">12675843</pub-id></element-citation></ref><ref id="B49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>R-C</given-names></name><name><surname>Saleem</surname><given-names>S</given-names></name><name><surname>Zhen</surname><given-names>G</given-names></name><etal/></person-group><article-title>Hemehemopexin complex attenuates neuronal cell death and stroke damage</article-title><source><italic>Journal of Cerebral Blood Flow &#x00026; Metabolism</italic></source><year>2009</year><volume>29</volume><issue>5</issue><fpage>953</fpage><lpage>964</lpage><pub-id pub-id-type="other">2-s2.0-65549152427</pub-id><pub-id pub-id-type="pmid">19277051</pub-id></element-citation></ref><ref id="B50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bechtel</surname><given-names>M</given-names></name><name><surname>Keller</surname><given-names>MV</given-names></name><name><surname>Bloch</surname><given-names>W</given-names></name><etal/></person-group><article-title>Different domains in nidogen-1 and nidogen-2 drive basement membrane formation in skin organotypic cocultures</article-title><source><italic>The FASEB Journal</italic></source><year>2012</year><volume>26</volume><issue>9</issue><fpage>3637</fpage><lpage>3648</lpage><pub-id pub-id-type="other">2-s2.0-84865762615</pub-id></element-citation></ref><ref id="B51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kohfeldt</surname><given-names>E</given-names></name><name><surname>Sasaki</surname><given-names>T</given-names></name><name><surname>G&#x000f6;hring</surname><given-names>W</given-names></name><name><surname>Timpl</surname><given-names>R</given-names></name></person-group><article-title>Nidogen-2: a new basement membrane protein with diverse binding properties</article-title><source><italic>Journal of Molecular Biology</italic></source><year>1998</year><volume>282</volume><issue>1</issue><fpage>99</fpage><lpage>109</lpage><pub-id pub-id-type="other">2-s2.0-0032508461</pub-id><pub-id pub-id-type="pmid">9733643</pub-id></element-citation></ref><ref id="B52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murshed</surname><given-names>M</given-names></name><name><surname>Smyth</surname><given-names>N</given-names></name><name><surname>Miosge</surname><given-names>N</given-names></name><etal/></person-group><article-title>The absence of nidogen 1 does not affect murine basement membrane formation</article-title><source><italic>Molecular and Cellular Biology</italic></source><year>2000</year><volume>20</volume><issue>18</issue><fpage>7007</fpage><lpage>7012</lpage><pub-id pub-id-type="other">2-s2.0-0033821010</pub-id><pub-id pub-id-type="pmid">10958695</pub-id></element-citation></ref><ref id="B53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salmivirta</surname><given-names>K</given-names></name><name><surname>Talts</surname><given-names>JF</given-names></name><name><surname>Olsson</surname><given-names>M</given-names></name><name><surname>Sasaki</surname><given-names>T</given-names></name><name><surname>Timpl</surname><given-names>R</given-names></name><name><surname>Ekblom</surname><given-names>P</given-names></name></person-group><article-title>Binding of mouse nidogen-2 to basement membrane components and cells and its expression in embryonic and adult tissues suggest complementary functions of the two nidogens</article-title><source><italic>Experimental Cell Research</italic></source><year>2002</year><volume>279</volume><issue>2</issue><fpage>188</fpage><lpage>201</lpage><pub-id pub-id-type="other">2-s2.0-0036405396</pub-id><pub-id pub-id-type="pmid">12243745</pub-id></element-citation></ref><ref id="B54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fox</surname><given-names>JW</given-names></name><name><surname>Mayer</surname><given-names>U</given-names></name><name><surname>Nischt</surname><given-names>R</given-names></name><etal/></person-group><article-title>Recombinant nidogen consists of three globular domains and mediates binding of laminin to collagen type IV</article-title><source><italic>EMBO Journal</italic></source><year>1991</year><volume>10</volume><issue>11</issue><fpage>3137</fpage><lpage>3146</lpage><pub-id pub-id-type="other">2-s2.0-0026006388</pub-id><pub-id pub-id-type="pmid">1717261</pub-id></element-citation></ref><ref id="B55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname><given-names>MSP</given-names></name><name><surname>B&#x000f6;se</surname><given-names>K</given-names></name><name><surname>Mokkapati</surname><given-names>S</given-names></name><name><surname>Nischt</surname><given-names>R</given-names></name><name><surname>Smyth</surname><given-names>N</given-names></name></person-group><article-title>Nidogens-extracellular matrix linker molecules</article-title><source><italic>Microscopy Research and Technique</italic></source><year>2008</year><volume>71</volume><issue>5</issue><fpage>387</fpage><lpage>395</lpage><pub-id pub-id-type="other">2-s2.0-42949163951</pub-id><pub-id pub-id-type="pmid">18219668</pub-id></element-citation></ref><ref id="B56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chakravarti</surname><given-names>S</given-names></name><name><surname>Tam</surname><given-names>MF</given-names></name><name><surname>Chung</surname><given-names>AE</given-names></name></person-group><article-title>The basement membrane glycoprotein entactin promotes cell attachment and binds calcium ions</article-title><source><italic>The Journal of Biological Chemistry</italic></source><year>1990</year><volume>265</volume><issue>18</issue><fpage>10597</fpage><lpage>10603</lpage><pub-id pub-id-type="other">2-s2.0-0025333863</pub-id><pub-id pub-id-type="pmid">2191952</pub-id></element-citation></ref><ref id="B57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Senior</surname><given-names>RM</given-names></name><name><surname>Gresham</surname><given-names>HD</given-names></name><name><surname>Griffin</surname><given-names>GL</given-names></name><name><surname>Brown</surname><given-names>EJ</given-names></name><name><surname>Chung</surname><given-names>AE</given-names></name></person-group><article-title>Entactin stimulates neutrophil adhesion and chemotaxis through interactions between its Arg-Gly-Asp (RGD) domain and the leukocyte response integrin</article-title><source><italic>Journal of Clinical Investigation</italic></source><year>1992</year><volume>90</volume><issue>6</issue><fpage>2251</fpage><lpage>2257</lpage><pub-id pub-id-type="other">2-s2.0-0027102384</pub-id><pub-id pub-id-type="pmid">1469085</pub-id></element-citation></ref><ref id="B58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yelian</surname><given-names>FD</given-names></name><name><surname>Edgeworth</surname><given-names>NA</given-names></name><name><surname>Dong</surname><given-names>L-J</given-names></name><name><surname>Chung</surname><given-names>AE</given-names></name><name><surname>Armant</surname><given-names>DR</given-names></name></person-group><article-title>Recombinant entactin promotes mouse primary trophoblast cell adhesion and migration through the Arg-Gly-Asp (RGD) recognition sequence</article-title><source><italic>Journal of Cell Biology</italic></source><year>1993</year><volume>121</volume><issue>4</issue><fpage>923</fpage><lpage>929</lpage><pub-id pub-id-type="other">2-s2.0-0027285725</pub-id><pub-id pub-id-type="pmid">8491783</pub-id></element-citation></ref><ref id="B59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicosia</surname><given-names>RF</given-names></name><name><surname>Nicosia</surname><given-names>SV</given-names></name><name><surname>Smith</surname><given-names>M</given-names></name></person-group><article-title>Vascular endothelial growth factor, platelet-derived growth factor, and insulin-like growth factor-1 promote rat aortic angiogenesis in vitro</article-title><source><italic>The American Journal of Pathology</italic></source><year>1994</year><volume>145</volume><issue>5</issue><fpage>1023</fpage><lpage>1029</lpage><pub-id pub-id-type="other">2-s2.0-0028139239</pub-id><pub-id pub-id-type="pmid">7526691</pub-id></element-citation></ref><ref id="B60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimura</surname><given-names>N</given-names></name><name><surname>Toyoshima</surname><given-names>T</given-names></name><name><surname>Kojima</surname><given-names>T</given-names></name><name><surname>Shimane</surname><given-names>M</given-names></name></person-group><article-title>Entactin-2: a new member of basement membrane protein with high homology to entactin/nidogen</article-title><source><italic>Experimental Cell Research</italic></source><year>1998</year><volume>241</volume><issue>1</issue><fpage>36</fpage><lpage>45</lpage><pub-id pub-id-type="other">2-s2.0-0031820133</pub-id><pub-id pub-id-type="pmid">9633511</pub-id></element-citation></ref><ref id="B61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neu</surname><given-names>R</given-names></name><name><surname>Adams</surname><given-names>S</given-names></name><name><surname>Munz</surname><given-names>B</given-names></name></person-group><article-title>Differential expression of entactin-1/nidogen-1 and entactin-2/nidogen-2 in myogenic differentiation</article-title><source><italic>Differentiation</italic></source><year>2006</year><volume>74</volume><issue>9-10</issue><fpage>573</fpage><lpage>582</lpage><pub-id pub-id-type="other">2-s2.0-33845528095</pub-id><pub-id pub-id-type="pmid">17177854</pub-id></element-citation></ref><ref id="B62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gr&#x000fc;newald</surname><given-names>FS</given-names></name><name><surname>Prota</surname><given-names>AE</given-names></name><name><surname>Giese</surname><given-names>A</given-names></name><name><surname>Ballmer-Hofer</surname><given-names>K</given-names></name></person-group><article-title>Structure-function analysis of VEGF receptor activation and the role of coreceptors in angiogenic signaling</article-title><source><italic>Biochimica et Biophysica Acta: Proteins and Proteomics</italic></source><year>2010</year><volume>1804</volume><issue>3</issue><fpage>567</fpage><lpage>580</lpage><pub-id pub-id-type="other">2-s2.0-75349091269</pub-id></element-citation></ref><ref id="B63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terman</surname><given-names>BI</given-names></name><name><surname>Carrion</surname><given-names>ME</given-names></name><name><surname>Kovacs</surname><given-names>E</given-names></name><name><surname>Rasmussen</surname><given-names>BA</given-names></name><name><surname>Eddy</surname><given-names>RL</given-names></name><name><surname>Shows</surname><given-names>TB</given-names></name></person-group><article-title>Identification of a new endothelial cell growth factor receptor tyrosine kinase</article-title><source><italic>Oncogene</italic></source><year>1991</year><volume>6</volume><issue>9</issue><fpage>1677</fpage><lpage>1683</lpage><pub-id pub-id-type="other">2-s2.0-0025739016</pub-id><pub-id pub-id-type="pmid">1656371</pub-id></element-citation></ref><ref id="B64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shibuya</surname><given-names>M</given-names></name><name><surname>Yamaguchi</surname><given-names>S</given-names></name><name><surname>Yamane</surname><given-names>A</given-names></name><etal/></person-group><article-title>Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely relatd to the fms family</article-title><source><italic>Oncogene</italic></source><year>1990</year><volume>5</volume><issue>4</issue><fpage>519</fpage><lpage>524</lpage><pub-id pub-id-type="other">2-s2.0-0025259592</pub-id><pub-id pub-id-type="pmid">2158038</pub-id></element-citation></ref><ref id="B65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pajusola</surname><given-names>K</given-names></name><name><surname>Aprelikova</surname><given-names>O</given-names></name><name><surname>Korhonen</surname><given-names>J</given-names></name><etal/></person-group><article-title>FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines</article-title><source><italic>Cancer Research</italic></source><year>1992</year><volume>52</volume><issue>20</issue><fpage>5738</fpage><lpage>5743</lpage><pub-id pub-id-type="other">2-s2.0-0026699255</pub-id><pub-id pub-id-type="pmid">1327515</pub-id></element-citation></ref><ref id="B66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neufeld</surname><given-names>G</given-names></name><name><surname>Kessler</surname><given-names>O</given-names></name><name><surname>Herzog</surname><given-names>Y</given-names></name></person-group><article-title>The interaction of neuropilin-1 and neurropilin-2 with tyrosine-kinase receptors for VEGF</article-title><source><italic>Advances in Experimental Medicine and Biology</italic></source><year>2002</year><volume>5</volume><issue>15</issue><fpage>81</fpage><lpage>90</lpage><pub-id pub-id-type="other">2-s2.0-0036941610</pub-id><pub-id pub-id-type="pmid">12613545</pub-id></element-citation></ref><ref id="B67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tessler</surname><given-names>S</given-names></name><name><surname>Rockwell</surname><given-names>P</given-names></name><name><surname>Hicklin</surname><given-names>D</given-names></name><etal/></person-group><article-title>Heparin modulates the interaction of VEGF165 with soluble and cell associated flk-1 receptors</article-title><source><italic>Journal of Biological Chemistry</italic></source><year>1994</year><volume>269</volume><issue>17</issue><fpage>12456</fpage><lpage>12461</lpage><pub-id pub-id-type="other">2-s2.0-0028336966</pub-id><pub-id pub-id-type="pmid">8175651</pub-id></element-citation></ref><ref id="B68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishi</surname><given-names>J</given-names></name><name><surname>Minamino</surname><given-names>T</given-names></name><name><surname>Miyauchi</surname><given-names>H</given-names></name><etal/></person-group><article-title>Vascular endothelial growth factor receptor-1 regulates postnatal angiogenesis through inhibition of the excessive activation of Akt</article-title><source><italic>Circulation Research</italic></source><year>2008</year><volume>103</volume><issue>3</issue><fpage>261</fpage><lpage>268</lpage><pub-id pub-id-type="other">2-s2.0-53549123579</pub-id><pub-id pub-id-type="pmid">18583712</pub-id></element-citation></ref><ref id="B69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fong</surname><given-names>G-H</given-names></name><name><surname>Rossant</surname><given-names>J</given-names></name><name><surname>Gertsenstein</surname><given-names>M</given-names></name><name><surname>Breitman</surname><given-names>ML</given-names></name></person-group><article-title>Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium</article-title><source><italic>Nature</italic></source><year>1995</year><volume>376</volume><issue>6535</issue><fpage>66</fpage><lpage>70</lpage><pub-id pub-id-type="other">2-s2.0-0029021660</pub-id><pub-id pub-id-type="pmid">7596436</pub-id></element-citation></ref><ref id="B70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fong</surname><given-names>G</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Bryce</surname><given-names>D</given-names></name><name><surname>Peng</surname><given-names>J</given-names></name></person-group><article-title>Increased hemangioblast commitment, not vascular disorganization, is the primary defect in flt-1 knock-out mice</article-title><source><italic>Development</italic></source><year>1999</year><volume>126</volume><issue>13</issue><fpage>3015</fpage><lpage>3025</lpage><pub-id pub-id-type="other">2-s2.0-0032764427</pub-id><pub-id pub-id-type="pmid">10357944</pub-id></element-citation></ref><ref id="B71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kearney</surname><given-names>JB</given-names></name><name><surname>Ambler</surname><given-names>CA</given-names></name><name><surname>Monaco</surname><given-names>K-A</given-names></name><name><surname>Johnson</surname><given-names>N</given-names></name><name><surname>Rapoport</surname><given-names>RG</given-names></name><name><surname>Bautch</surname><given-names>VL</given-names></name></person-group><article-title>Vascular endothelial growth factor receptor Flt-1 negatively regulates developmental blood vessel formation by modulating endothelial cell division</article-title><source><italic>Blood</italic></source><year>2002</year><volume>99</volume><issue>7</issue><fpage>2397</fpage><lpage>2407</lpage><pub-id pub-id-type="other">2-s2.0-0036530222</pub-id><pub-id pub-id-type="pmid">11895772</pub-id></element-citation></ref><ref id="B72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>B</given-names></name><name><surname>Jeong</surname><given-names>W</given-names></name><name><surname>Tian</surname><given-names>Z</given-names></name></person-group><article-title>Liver: an organ with predominant innate immunity</article-title><source><italic>Hepatology</italic></source><year>2008</year><volume>47</volume><issue>2</issue><fpage>729</fpage><lpage>736</lpage><pub-id pub-id-type="other">2-s2.0-39549097751</pub-id><pub-id pub-id-type="pmid">18167066</pub-id></element-citation></ref><ref id="B73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bieghs</surname><given-names>V</given-names></name><name><surname>Trautwein</surname><given-names>C</given-names></name></person-group><article-title>The innate immune response during liver inflammation and metabolic disease</article-title><source><italic>Trends in Immunology</italic></source><year>2013</year><volume>34</volume><issue>9</issue><fpage>446</fpage><lpage>452</lpage><pub-id pub-id-type="other">2-s2.0-84877139983</pub-id><pub-id pub-id-type="pmid">23668977</pub-id></element-citation></ref><ref id="B74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Charrasse</surname><given-names>S</given-names></name><name><surname>Causeret</surname><given-names>M</given-names></name><name><surname>Comunale</surname><given-names>F</given-names></name><name><surname>Bonet-Kerrache</surname><given-names>A</given-names></name><name><surname>Gauthier-Rouvi&#x000e8;re</surname><given-names>C</given-names></name></person-group><article-title>Rho GTPases and cadherin-based cell adhesion in skeletal muscle development</article-title><source><italic>Journal of Muscle Research and Cell Motility</italic></source><year>2003</year><volume>24</volume><issue>4&#x02013;6</issue><fpage>309</fpage><lpage>313</lpage><pub-id pub-id-type="other">2-s2.0-0142249450</pub-id><pub-id pub-id-type="pmid">14620744</pub-id></element-citation></ref><ref id="B75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knudsen</surname><given-names>KA</given-names></name><name><surname>Myers</surname><given-names>L</given-names></name><name><surname>McElwee</surname><given-names>SA</given-names></name></person-group><article-title>A role for the Ca<sup>2+</sup>-dependent adhesion molecule, N-Cadherin, in myoblast interaction during myogenesis</article-title><source><italic>Experimental Cell Research</italic></source><year>1990</year><volume>188</volume><issue>2</issue><fpage>175</fpage><lpage>184</lpage><pub-id pub-id-type="other">2-s2.0-0025195125</pub-id><pub-id pub-id-type="pmid">2335185</pub-id></element-citation></ref><ref id="B76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>RK</given-names></name><name><surname>Nakatani</surname><given-names>Y</given-names></name><name><surname>Yanagisawa</surname><given-names>M</given-names></name></person-group><article-title>The role of glycosphingolipid metabolism in the developing brain</article-title><source><italic>Journal of Lipid Research</italic></source><year>2009</year><volume>50</volume><fpage>S440</fpage><lpage>S445</lpage><pub-id pub-id-type="other">2-s2.0-66349103103</pub-id><pub-id pub-id-type="pmid">18845618</pub-id></element-citation></ref><ref id="B77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Svennerholm</surname><given-names>L</given-names></name><name><surname>Bostrom</surname><given-names>K</given-names></name><name><surname>Fredman</surname><given-names>P</given-names></name><name><surname>M&#x000e5;nsson</surname><given-names>JE</given-names></name><name><surname>Rosengren</surname><given-names>B</given-names></name><name><surname>Rynmark</surname><given-names>BM</given-names></name></person-group><article-title>Human brain gangliosides: developmental changes from early fetal stage to advanced age</article-title><source><italic>Biochimica et Biophysica Acta</italic></source><year>1989</year><volume>1005</volume><issue>2</issue><fpage>109</fpage><lpage>117</lpage><pub-id pub-id-type="other">2-s2.0-0024341819</pub-id><pub-id pub-id-type="pmid">2775765</pub-id></element-citation></ref><ref id="B78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>RK</given-names></name><name><surname>Macala</surname><given-names>LJ</given-names></name><name><surname>Taki</surname><given-names>T</given-names></name><name><surname>Weinfeld</surname><given-names>HM</given-names></name><name><surname>Yu</surname><given-names>FS</given-names></name></person-group><article-title>Developmental changes in ganglioside composition and synthesis in embryonic rat brain</article-title><source><italic>Journal of Neurochemistry</italic></source><year>1988</year><volume>50</volume><issue>6</issue><fpage>1825</fpage><lpage>1829</lpage><pub-id pub-id-type="other">2-s2.0-0023951111</pub-id><pub-id pub-id-type="pmid">3131485</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="fig1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Flowchart depicting the overall methodology adopted in this study.</p></caption><graphic xlink:href="IJG2014-837365.001"/></fig><fig id="fig2" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Interaction networks between DEGGs and additional related genes: (a) BvL579, (b) BvM501, and (c) LvM442. In each of these networks, red indicates a DEGG whereas the GeneMANIA predicted genes are shown in cyan. The top two hubs are shown as purple diamonds. The size of the nodes represents the node degree.</p></caption><graphic xlink:href="IJG2014-837365.002"/></fig><fig id="fig3" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Top glycogenes as hubs and their first neighbors. (a)<italic> HPXN</italic> gene as hubs in BvL579 interaction network. (b)<italic> NID2</italic> as hub gene in BvM501 interaction network. (c)<italic> FLT1</italic> gene as hub in LvM442 interaction network.</p></caption><graphic xlink:href="IJG2014-837365.003"/></fig><fig id="fig4" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Communities generated by fast greedy (GLay) clustering algorithm are shown. Clusters for (a) BvL579 network, (b) BvM501 network, and (c) LvM442 network are shown. In each community, DEGG nodes are represented by red circles whereas the cyan nodes represent GeneMANIA predicted genes. Hub genes are shown as purple diamonds.</p></caption><graphic xlink:href="IJG2014-837365.004"/></fig><table-wrap-group id="tab1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Gene expression summary.</p></caption><table-wrap id="tab1a" orientation="portrait" position="anchor"><caption><p>(a) Total number of genes in each sample before and after filtering. Each tissue sample consists of 33598 genes that were filtered by removing all those genes that showed RPKM value &#x0003c; 1</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">&#x02009;</th><th align="center" colspan="2" rowspan="1">Data filtering</th></tr><tr><th align="left" rowspan="1" colspan="1">Tissue</th><th align="center" rowspan="1" colspan="1">Total number of genes</th><th align="center" rowspan="1" colspan="1">Total number of genes after filtering</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Brain</td><td align="center" rowspan="1" colspan="1">33598</td><td align="center" rowspan="1" colspan="1">15,237</td></tr><tr><td align="left" rowspan="1" colspan="1">Liver</td><td align="center" rowspan="1" colspan="1">33598</td><td align="center" rowspan="1" colspan="1">11,920</td></tr><tr><td align="left" rowspan="1" colspan="1">Muscle</td><td align="center" rowspan="1" colspan="1">33598</td><td align="center" rowspan="1" colspan="1">12,202</td></tr></tbody></table></table-wrap><table-wrap id="tab1b" orientation="portrait" position="anchor"><caption><p>(b) Total number of differentially expressed genes between different tissues</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">&#x02009;</th><th align="center" colspan="3" rowspan="1">Genes commonly expressed between different tissues</th></tr><tr><th align="left" rowspan="1" colspan="1">Tissue</th><th align="center" rowspan="1" colspan="1">Number of expressed genes</th><th align="center" rowspan="1" colspan="1">Number of differentially expressed genes (DEGs)&#x02009;<break/>(&#x02265;2 fold change)</th><th align="center" rowspan="1" colspan="1">Number of differentially expressed glycogenes (DEGGs)&#x02009;<break/>(&#x02265;2 fold change)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Brain versus liver</td><td align="center" rowspan="1" colspan="1">10,653</td><td align="center" rowspan="1" colspan="1">5228</td><td align="center" rowspan="1" colspan="1">579</td></tr><tr><td align="left" rowspan="1" colspan="1">Brain versus muscle</td><td align="center" rowspan="1" colspan="1">10,820</td><td align="center" rowspan="1" colspan="1">5283</td><td align="center" rowspan="1" colspan="1">501</td></tr><tr><td align="left" rowspan="1" colspan="1">Liver versus muscle</td><td align="center" rowspan="1" colspan="1">9,833</td><td align="center" rowspan="1" colspan="1">3840</td><td align="center" rowspan="1" colspan="1">442</td></tr></tbody></table></table-wrap></table-wrap-group><table-wrap-group id="tab2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Top 10 significantly enriched gene ontology (GO) terms detected by FAC in differentially expressed glycogenes between (a) BvL579, (b) BvM501, and (c) LvM442. Only those terms which reported a <italic>P</italic> value of &#x02264;0.05 and count number &#x02265;5 genes were selected for the analysis. </p></caption><table-wrap id="tab2a" orientation="portrait" position="anchor"><caption><p>(a) BvL579</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">GO Term</th><th align="center" rowspan="1" colspan="1">Total number of genes</th><th align="center" rowspan="1" colspan="1">
<italic>P</italic> value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">GO:0009611~response to wounding</td><td align="center" rowspan="1" colspan="1">53</td><td align="center" rowspan="1" colspan="1">2.98<italic>E &#x02212; </italic>23</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0002526~acute inflammatory response</td><td align="center" rowspan="1" colspan="1">23</td><td align="center" rowspan="1" colspan="1">4.83<italic>E &#x02212; </italic>16</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0006954~inflammatory response</td><td align="center" rowspan="1" colspan="1">35</td><td align="center" rowspan="1" colspan="1">1.43<italic>E &#x02212; </italic>15</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0051604~protein maturation</td><td align="center" rowspan="1" colspan="1">23</td><td align="center" rowspan="1" colspan="1">2.51<italic>E &#x02212; </italic>14</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0007596~blood coagulation</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">5.40<italic>E &#x02212; </italic>14</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0050817~coagulation</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">5.40<italic>E &#x02212; </italic>14</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0007599~hemostasis</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">7.17<italic>E &#x02212; </italic>14</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0006952~defense response</td><td align="center" rowspan="1" colspan="1">45</td><td align="center" rowspan="1" colspan="1">7.57<italic>E &#x02212; </italic>13</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0050878~regulation of body fluid levels</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">5.84<italic>E &#x02212; </italic>12</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0016485~protein processing</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">7.21<italic>E &#x02212; </italic>12</td></tr></tbody></table></table-wrap><table-wrap id="tab2b" orientation="portrait" position="anchor"><caption><p>(b) BvM501</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">GO Term</th><th align="center" rowspan="1" colspan="1">Total number of genes</th><th align="center" rowspan="1" colspan="1">
<italic>P</italic> value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">GO:0009100~glycoprotein metabolic process</td><td align="center" rowspan="1" colspan="1">30</td><td align="center" rowspan="1" colspan="1">1.76<italic>E &#x02212; </italic>18</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0009101~glycoprotein biosynthetic process</td><td align="center" rowspan="1" colspan="1">23</td><td align="center" rowspan="1" colspan="1">8.1<italic>E &#x02212; </italic>14</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0070085~glycosylation</td><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">6.09<italic>E &#x02212; </italic>10</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0006486~protein amino acid glycosylation</td><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">6.09<italic>E &#x02212; </italic>10</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0043413~biopolymer glycosylation</td><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">6.09<italic>E &#x02212; </italic>10</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0030203~glycosaminoglycan metabolic process</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">3.1<italic>E &#x02212; </italic>08</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0006665~sphingolipid metabolic process</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">2.79<italic>E &#x02212; </italic>07</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0006643~membrane lipid metabolic process</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">3.9<italic>E &#x02212; </italic>07</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0006022~aminoglycan metabolic process</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">4.45<italic>E &#x02212; </italic>07</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0051604~protein maturation</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">6.1<italic>E &#x02212; </italic>07</td></tr></tbody></table></table-wrap><table-wrap id="tab2c" orientation="portrait" position="anchor"><caption><p>(c) LvM442</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">GO Term</th><th align="center" rowspan="1" colspan="1">Total number of genes</th><th align="center" rowspan="1" colspan="1">
<italic>P</italic> value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">GO:0051604~protein maturation</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">3.17<italic>E &#x02212; </italic>13</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0016485~protein processing</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">1.12<italic>E &#x02212; </italic>12</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0009100~glycoprotein metabolic process</td><td align="center" rowspan="1" colspan="1">23</td><td align="center" rowspan="1" colspan="1">1.63<italic>E &#x02212; </italic>12</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0006954~inflammatory response</td><td align="center" rowspan="1" colspan="1">27</td><td align="center" rowspan="1" colspan="1">6.69<italic>E &#x02212; </italic>12</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0009611~response to wounding</td><td align="center" rowspan="1" colspan="1">33</td><td align="center" rowspan="1" colspan="1">1.07<italic>E &#x02212; </italic>11</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0002526~acute inflammatory response</td><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">2.53<italic>E &#x02212; </italic>11</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0009101~glycoprotein biosynthetic process</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">1.14<italic>E &#x02212; </italic>10</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0051605~protein maturation by peptide bond cleavage</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">1.33<italic>E &#x02212; </italic>10</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0006956~complement activation</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">4.25<italic>E &#x02212; </italic>09</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0002541~activation of plasma proteins involved in acute inflammatory response</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">4.25<italic>E &#x02212; </italic>09</td></tr></tbody></table></table-wrap></table-wrap-group><table-wrap-group id="tab3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Top 10 KEGG pathways for DEGGs in each category. (a) BvL579, (b) BvM501, and (c) LvM442.</p></caption><table-wrap id="tab3a" orientation="portrait" position="anchor"><caption><p>(a) BvL579</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Pathway name</th><th align="center" rowspan="1" colspan="1">Number of mapped Genes</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">04151 PI3K-Akt signaling pathway</td><td align="center" rowspan="1" colspan="1">34</td></tr><tr><td align="left" rowspan="1" colspan="1">04610 Complement and coagulation cascades</td><td align="center" rowspan="1" colspan="1">34</td></tr><tr><td align="left" rowspan="1" colspan="1">04142 Lysosome</td><td align="center" rowspan="1" colspan="1">31</td></tr><tr><td align="left" rowspan="1" colspan="1">04060 Cytokine-cytokine receptor interaction</td><td align="center" rowspan="1" colspan="1">23</td></tr><tr><td align="left" rowspan="1" colspan="1">05200 Pathways in cancer</td><td align="center" rowspan="1" colspan="1">21</td></tr><tr><td align="left" rowspan="1" colspan="1">04015 Rap1 signaling pathway</td><td align="center" rowspan="1" colspan="1">18</td></tr><tr><td align="left" rowspan="1" colspan="1">04510 Focal adhesion</td><td align="center" rowspan="1" colspan="1">18</td></tr><tr><td align="left" rowspan="1" colspan="1">05205 Proteoglycans in cancer</td><td align="center" rowspan="1" colspan="1">18</td></tr><tr><td align="left" rowspan="1" colspan="1">04514 Cell adhesion molecules CAMs</td><td align="center" rowspan="1" colspan="1">16</td></tr><tr><td align="left" rowspan="1" colspan="1">04976 Bile secretion</td><td align="center" rowspan="1" colspan="1">16</td></tr></tbody></table></table-wrap><table-wrap id="tab3b" orientation="portrait" position="anchor"><caption><p>(b) BvM501</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Pathway name</th><th align="center" rowspan="1" colspan="1">Number of mapped Genes</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">04142 Lysosome</td><td align="center" rowspan="1" colspan="1">29</td></tr><tr><td align="left" rowspan="1" colspan="1">04151 PI3K-Akt signaling pathway</td><td align="center" rowspan="1" colspan="1">24</td></tr><tr><td align="left" rowspan="1" colspan="1">04060 Cytokine-cytokine receptor interaction</td><td align="center" rowspan="1" colspan="1">19</td></tr><tr><td align="left" rowspan="1" colspan="1">04514 Cell adhesion molecules CAMs</td><td align="center" rowspan="1" colspan="1">19</td></tr><tr><td align="left" rowspan="1" colspan="1">05200 Pathways in cancer</td><td align="center" rowspan="1" colspan="1">17</td></tr><tr><td align="left" rowspan="1" colspan="1">04141 Protein processing in endoplasmic reticulum</td><td align="center" rowspan="1" colspan="1">15</td></tr><tr><td align="left" rowspan="1" colspan="1">04510 Focal adhesion</td><td align="center" rowspan="1" colspan="1">15</td></tr><tr><td align="left" rowspan="1" colspan="1">05166 HTLV-I infection</td><td align="center" rowspan="1" colspan="1">13</td></tr><tr><td align="left" rowspan="1" colspan="1">04512 ECM-receptor interaction</td><td align="center" rowspan="1" colspan="1">12</td></tr><tr><td align="left" rowspan="1" colspan="1">04610 Complement and coagulation cascades</td><td align="center" rowspan="1" colspan="1">12</td></tr></tbody></table></table-wrap><table-wrap id="tab3c" orientation="portrait" position="anchor"><caption><p>(c) LvM442</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Pathway name</th><th align="center" rowspan="1" colspan="1">Number of mapped Genes</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">04142 Lysosome</td><td align="center" rowspan="1" colspan="1">33</td></tr><tr><td align="left" rowspan="1" colspan="1">04151 PI3K-Akt signaling pathway</td><td align="center" rowspan="1" colspan="1">26</td></tr><tr><td align="left" rowspan="1" colspan="1">04060 Cytokine-cytokine receptor interaction</td><td align="center" rowspan="1" colspan="1">23</td></tr><tr><td align="left" rowspan="1" colspan="1">04141 Protein processing in endoplasmic reticulum</td><td align="center" rowspan="1" colspan="1">17</td></tr><tr><td align="left" rowspan="1" colspan="1">05205 Proteoglycans in cancer</td><td align="center" rowspan="1" colspan="1">17</td></tr><tr><td align="left" rowspan="1" colspan="1">04610 Complement and coagulation cascades</td><td align="center" rowspan="1" colspan="1">15</td></tr><tr><td align="left" rowspan="1" colspan="1">04514 Cell adhesion molecules CAMs</td><td align="center" rowspan="1" colspan="1">14</td></tr><tr><td align="left" rowspan="1" colspan="1">04510 Focal adhesion</td><td align="center" rowspan="1" colspan="1">14</td></tr><tr><td align="left" rowspan="1" colspan="1">04512 ECM-receptor interaction</td><td align="center" rowspan="1" colspan="1">13</td></tr><tr><td align="left" rowspan="1" colspan="1">04145 Phagosome</td><td align="center" rowspan="1" colspan="1">13</td></tr></tbody></table></table-wrap></table-wrap-group><table-wrap-group id="tab4" orientation="portrait" position="float"><label>Table 4</label><caption><p>10 enriched gene ontology (GO) terms for DEGGs and additional related genes as reported by GeneMANIA for each category (a) BvL579, (b) BvM501, and (c) LvM442.</p></caption><table-wrap id="tab4a" orientation="portrait" position="anchor"><caption><p>(a) BvL579</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">GO id</th><th align="center" rowspan="1" colspan="1">Description</th><th align="center" rowspan="1" colspan="1">
<italic>q</italic>-value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">GO:0040017</td><td align="center" rowspan="1" colspan="1">positive regulation of locomotion</td><td align="center" rowspan="1" colspan="1">1.83<italic>E &#x02212; </italic>23</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:2000147</td><td align="center" rowspan="1" colspan="1">positive regulation of cell motility</td><td align="center" rowspan="1" colspan="1">1.83<italic>E &#x02212; </italic>23</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0030335</td><td align="center" rowspan="1" colspan="1">positive regulation of cell migration</td><td align="center" rowspan="1" colspan="1">3.40<italic>E &#x02212; </italic>23</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0051272</td><td align="center" rowspan="1" colspan="1">positive regulation of cellular component movement</td><td align="center" rowspan="1" colspan="1">3.40<italic>E &#x02212; </italic>23</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0050817</td><td align="center" rowspan="1" colspan="1">coagulation</td><td align="center" rowspan="1" colspan="1">1.94<italic>E &#x02212; </italic>20</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0010876</td><td align="center" rowspan="1" colspan="1">lipid localization</td><td align="center" rowspan="1" colspan="1">3.80<italic>E &#x02212; </italic>20</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0007596</td><td align="center" rowspan="1" colspan="1">blood coagulation</td><td align="center" rowspan="1" colspan="1">4.54<italic>E &#x02212; </italic>20</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0007599</td><td align="center" rowspan="1" colspan="1">hemostasis</td><td align="center" rowspan="1" colspan="1">7.56<italic>E &#x02212; </italic>20</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0009897</td><td align="center" rowspan="1" colspan="1">external side of plasma membrane</td><td align="center" rowspan="1" colspan="1">2.15<italic>E &#x02212; </italic>18</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0000323</td><td align="center" rowspan="1" colspan="1">lytic vacuole</td><td align="center" rowspan="1" colspan="1">1.05<italic>E &#x02212; </italic>17</td></tr></tbody></table></table-wrap><table-wrap id="tab4b" orientation="portrait" position="anchor"><caption><p>(b) BvM501</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">GO id</th><th align="center" rowspan="1" colspan="1">Description</th><th align="center" rowspan="1" colspan="1">
<italic>q</italic>-value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">GO:0031012</td><td align="center" rowspan="1" colspan="1">extracellular matrix</td><td align="center" rowspan="1" colspan="1">2.43<italic>E &#x02212; </italic>23</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0005578</td><td align="center" rowspan="1" colspan="1">proteinaceous extracellular matrix</td><td align="center" rowspan="1" colspan="1">1.37<italic>E &#x02212; </italic>17</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0009100</td><td align="center" rowspan="1" colspan="1">glycoprotein metabolic process</td><td align="center" rowspan="1" colspan="1">1.99<italic>E &#x02212; </italic>16</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0000323</td><td align="center" rowspan="1" colspan="1">lytic vacuole</td><td align="center" rowspan="1" colspan="1">2.87<italic>E &#x02212; </italic>16</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0005764</td><td align="center" rowspan="1" colspan="1">lysosome</td><td align="center" rowspan="1" colspan="1">2.87<italic>E &#x02212; </italic>16</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0044420</td><td align="center" rowspan="1" colspan="1">extracellular matrix part</td><td align="center" rowspan="1" colspan="1">3.18<italic>E &#x02212; </italic>15</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0005604</td><td align="center" rowspan="1" colspan="1">basement membrane</td><td align="center" rowspan="1" colspan="1">1.20<italic>E &#x02212; </italic>14</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0005773</td><td align="center" rowspan="1" colspan="1">vacuole</td><td align="center" rowspan="1" colspan="1">4.56<italic>E &#x02212; </italic>14</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0030335</td><td align="center" rowspan="1" colspan="1">positive regulation of cell migration</td><td align="center" rowspan="1" colspan="1">5.17<italic>E &#x02212; </italic>12</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0005178</td><td align="center" rowspan="1" colspan="1">integrin binding</td><td align="center" rowspan="1" colspan="1">5.17<italic>E &#x02212; </italic>12</td></tr></tbody></table></table-wrap><table-wrap id="tab4c" orientation="portrait" position="anchor"><caption><p>(c) LvM442</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">GO id</th><th align="center" rowspan="1" colspan="1">Description</th><th align="center" rowspan="1" colspan="1">
<italic>q</italic>-value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">GO:0000323</td><td align="center" rowspan="1" colspan="1">lytic vacuole</td><td align="center" rowspan="1" colspan="1">1.09<italic>E &#x02212; </italic>20</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0005764</td><td align="center" rowspan="1" colspan="1">lysosome</td><td align="center" rowspan="1" colspan="1">1.09<italic>E &#x02212; </italic>20</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0051272</td><td align="center" rowspan="1" colspan="1">positive regulation of cellular component movement</td><td align="center" rowspan="1" colspan="1">8.78<italic>E &#x02212; </italic>20</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0030335</td><td align="center" rowspan="1" colspan="1">positive regulation of cell migration</td><td align="center" rowspan="1" colspan="1">1.04<italic>E &#x02212; </italic>19</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:2000147</td><td align="center" rowspan="1" colspan="1">positive regulation of cell motility</td><td align="center" rowspan="1" colspan="1">1.79<italic>E &#x02212; </italic>19</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0040017</td><td align="center" rowspan="1" colspan="1">positive regulation of locomotion</td><td align="center" rowspan="1" colspan="1">6.43<italic>E &#x02212; </italic>19</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0005773</td><td align="center" rowspan="1" colspan="1">vacuole</td><td align="center" rowspan="1" colspan="1">1.70<italic>E &#x02212; </italic>18</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0019838</td><td align="center" rowspan="1" colspan="1">growth factor binding</td><td align="center" rowspan="1" colspan="1">2.80<italic>E &#x02212; </italic>18</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0009100</td><td align="center" rowspan="1" colspan="1">glycoprotein metabolic process</td><td align="center" rowspan="1" colspan="1">2.11<italic>E &#x02212; </italic>15</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0031012</td><td align="center" rowspan="1" colspan="1">extracellular matrix</td><td align="center" rowspan="1" colspan="1">1.48<italic>E &#x02212; </italic>14</td></tr></tbody></table></table-wrap></table-wrap-group><table-wrap-group id="tab5" orientation="portrait" position="float"><label>Table 5</label><caption><p>Enrichment of GO terms for BvL579, BvM501, and LvM442 cluster analysis.</p></caption><table-wrap id="tab5a" orientation="portrait" position="anchor"><caption><p>(a) BvL579</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Cluster number</th><th align="left" rowspan="1" colspan="1">Term</th><th align="center" rowspan="1" colspan="1">
<italic>P</italic> value</th></tr></thead><tbody><tr><td align="left" rowspan="10" colspan="1">1</td><td align="left" rowspan="1" colspan="1">GO:0002541~activation of plasma proteins involved in acute inflammatory response</td><td align="center" rowspan="1" colspan="1">5.02<italic>E &#x02212; </italic>22</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0006956~complement activation</td><td align="center" rowspan="1" colspan="1">5.02<italic>E &#x02212; </italic>22</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0002526~acute inflammatory response</td><td align="center" rowspan="1" colspan="1">2.26<italic>E &#x02212; </italic>20</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0006959~humoral immune response</td><td align="center" rowspan="1" colspan="1">2.25<italic>E &#x02212; </italic>19</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0051604~protein maturation</td><td align="center" rowspan="1" colspan="1">3.43<italic>E &#x02212; </italic>19</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0051605~protein maturation by peptide bond cleavage</td><td align="center" rowspan="1" colspan="1">3.19<italic>E &#x02212; </italic>18</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0002253~activation of immune response</td><td align="center" rowspan="1" colspan="1">3.20<italic>E &#x02212; </italic>18</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0016485~protein processing</td><td align="center" rowspan="1" colspan="1">6.27<italic>E &#x02212; </italic>18</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0006957~complement activation, alternative pathway</td><td align="center" rowspan="1" colspan="1">8.91<italic>E &#x02212; </italic>18</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0006954~inflammatory response</td><td align="center" rowspan="1" colspan="1">1.44<italic>E &#x02212; </italic>17</td></tr><tr><td align="center" colspan="3" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="10" colspan="1">2</td><td align="left" rowspan="1" colspan="1">GO:0051094~positive regulation of developmental process</td><td align="center" rowspan="1" colspan="1">5.33<italic>E &#x02212; </italic>05</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0042592~homeostatic process</td><td align="center" rowspan="1" colspan="1">4.25<italic>E &#x02212; </italic>04</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0009611~response to wounding</td><td align="center" rowspan="1" colspan="1">7.29<italic>E &#x02212; </italic>04</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0001568~blood vessel development</td><td align="center" rowspan="1" colspan="1">9.88<italic>E &#x02212; </italic>04</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0001944~vasculature development</td><td align="center" rowspan="1" colspan="1">0.001101764</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0050817~coagulation</td><td align="center" rowspan="1" colspan="1">0.001394123</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0007596~blood coagulation</td><td align="center" rowspan="1" colspan="1">0.001394123</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0007599~hemostasis</td><td align="center" rowspan="1" colspan="1">0.001452434</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0050878~regulation of body fluid levels</td><td align="center" rowspan="1" colspan="1">0.002774109</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway</td><td align="center" rowspan="1" colspan="1">0.003100357</td></tr><tr><td align="center" colspan="3" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="10" colspan="1">3</td><td align="left" rowspan="1" colspan="1">GO:0050817~coagulation</td><td align="center" rowspan="1" colspan="1">2.74<italic>E &#x02212; </italic>11</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0007596~blood coagulation</td><td align="center" rowspan="1" colspan="1">2.74<italic>E &#x02212; </italic>11</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0007599~hemostasis</td><td align="center" rowspan="1" colspan="1">3.08<italic>E &#x02212; </italic>11</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0050878~regulation of body fluid levels</td><td align="center" rowspan="1" colspan="1">1.97<italic>E &#x02212; </italic>10</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0042060~wound healing</td><td align="center" rowspan="1" colspan="1">1.26<italic>E &#x02212; </italic>09</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0009611~response to wounding</td><td align="center" rowspan="1" colspan="1">5.75<italic>E &#x02212; </italic>08</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0007167~enzyme linked receptor protein signaling pathway</td><td align="center" rowspan="1" colspan="1">9.33<italic>E &#x02212; </italic>08</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0001568~blood vessel development</td><td align="center" rowspan="1" colspan="1">5.52<italic>E &#x02212; </italic>07</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0001944~vasculature development</td><td align="center" rowspan="1" colspan="1">6.64<italic>E &#x02212; </italic>07</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0001525~angiogenesis</td><td align="center" rowspan="1" colspan="1">4.71<italic>E &#x02212; </italic>05</td></tr><tr><td align="center" colspan="3" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="10" colspan="1">4</td><td align="left" rowspan="1" colspan="1">GO:0022404~molting cycle process</td><td align="center" rowspan="1" colspan="1">2.16<italic>E &#x02212; </italic>04</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0022405~hair cycle process</td><td align="center" rowspan="1" colspan="1">2.16<italic>E &#x02212; </italic>04</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0001942~hair follicle development</td><td align="center" rowspan="1" colspan="1">2.16<italic>E &#x02212; </italic>04</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0042633~hair cycle</td><td align="center" rowspan="1" colspan="1">2.42<italic>E &#x02212; </italic>04</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0042303~molting cycle</td><td align="center" rowspan="1" colspan="1">2.42<italic>E &#x02212; </italic>04</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0008544~epidermis development</td><td align="center" rowspan="1" colspan="1">0.003102493</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0007398~ectoderm development</td><td align="center" rowspan="1" colspan="1">0.00369522</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0050678~regulation of epithelial cell proliferation</td><td align="center" rowspan="1" colspan="1">0.009595347</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0048732~gland development</td><td align="center" rowspan="1" colspan="1">0.01092817</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0007173~epidermal growth factor receptor signaling pathway</td><td align="center" rowspan="1" colspan="1">0.025611634</td></tr><tr><td align="center" colspan="3" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="10" colspan="1">5</td><td align="left" rowspan="1" colspan="1">GO:0007166~cell surface receptor linked signal transduction</td><td align="center" rowspan="1" colspan="1">1.34<italic>E &#x02212; </italic>05</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0016477~cell migration</td><td align="center" rowspan="1" colspan="1">2.69<italic>E &#x02212; </italic>05</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0042127~regulation of cell proliferation</td><td align="center" rowspan="1" colspan="1">3.44<italic>E &#x02212; </italic>05</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0051674~localization of cell</td><td align="center" rowspan="1" colspan="1">4.88<italic>E &#x02212; </italic>05</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0048870~cell motility</td><td align="center" rowspan="1" colspan="1">4.88<italic>E &#x02212; </italic>05</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0006928~cell motion</td><td align="center" rowspan="1" colspan="1">6.35<italic>E &#x02212; </italic>05</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0008284~positive regulation of cell proliferation</td><td align="center" rowspan="1" colspan="1">2.52<italic>E &#x02212; </italic>04</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0007229~integrin-mediated signaling pathway</td><td align="center" rowspan="1" colspan="1">4.87<italic>E &#x02212; </italic>04</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0040007~growth</td><td align="center" rowspan="1" colspan="1">6.74<italic>E &#x02212; </italic>04</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0007507~heart development</td><td align="center" rowspan="1" colspan="1">0.001229375</td></tr><tr><td align="center" colspan="3" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="10" colspan="1">6</td><td align="left" rowspan="1" colspan="1">GO:0055088~lipid homeostasis</td><td align="center" rowspan="1" colspan="1">2.16<italic>E &#x02212; </italic>16</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0042632~cholesterol homeostasis</td><td align="center" rowspan="1" colspan="1">2.64<italic>E &#x02212; </italic>15</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0055092~sterol homeostasis</td><td align="center" rowspan="1" colspan="1">2.64<italic>E &#x02212; </italic>15</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0030301~cholesterol transport</td><td align="center" rowspan="1" colspan="1">3.97<italic>E &#x02212; </italic>13</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0015918~sterol transport</td><td align="center" rowspan="1" colspan="1">3.97<italic>E &#x02212; </italic>13</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0033344~cholesterol efflux</td><td align="center" rowspan="1" colspan="1">7.23<italic>E &#x02212; </italic>13</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0006869~lipid transport</td><td align="center" rowspan="1" colspan="1">3.89<italic>E &#x02212; </italic>12</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0008203~cholesterol metabolic process</td><td align="center" rowspan="1" colspan="1">4.74<italic>E &#x02212; </italic>12</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0010876~lipid localization</td><td align="center" rowspan="1" colspan="1">8.01<italic>E &#x02212; </italic>12</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0016125~sterol metabolic process</td><td align="center" rowspan="1" colspan="1">1.02<italic>E &#x02212; </italic>11</td></tr><tr><td align="center" colspan="3" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="10" colspan="1">7</td><td align="left" rowspan="1" colspan="1">GO:0009611~response to wounding</td><td align="center" rowspan="1" colspan="1">3.88<italic>E &#x02212; </italic>07</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0007596~blood coagulation</td><td align="center" rowspan="1" colspan="1">2.94<italic>E &#x02212; </italic>06</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0050817~coagulation</td><td align="center" rowspan="1" colspan="1">2.94<italic>E &#x02212; </italic>06</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0007599~hemostasis</td><td align="center" rowspan="1" colspan="1">3.11<italic>E &#x02212; </italic>06</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0050878~regulation of body fluid levels</td><td align="center" rowspan="1" colspan="1">7.69<italic>E &#x02212; </italic>06</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0042060~wound healing</td><td align="center" rowspan="1" colspan="1">1.91<italic>E &#x02212; </italic>05</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0051818~disruption of cells of other organism during symbiotic interaction</td><td align="center" rowspan="1" colspan="1">3.08<italic>E &#x02212; </italic>05</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0051851~modification by host of symbiont morphology or physiology</td><td align="center" rowspan="1" colspan="1">3.08<italic>E &#x02212; </italic>05</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0051883~killing of cells in other organism during symbiotic interaction</td><td align="center" rowspan="1" colspan="1">3.08<italic>E &#x02212; </italic>05</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0031640~killing of cells of another organism</td><td align="center" rowspan="1" colspan="1">4.30<italic>E &#x02212; </italic>05</td></tr><tr><td align="center" colspan="3" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="10" colspan="1">8</td><td align="left" rowspan="1" colspan="1">GO:0006689~ganglioside catabolic process</td><td align="center" rowspan="1" colspan="1">5.11<italic>E &#x02212; </italic>06</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0046479~glycosphingolipid catabolic process</td><td align="center" rowspan="1" colspan="1">1.79<italic>E &#x02212; </italic>05</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0019377~glycolipid catabolic process</td><td align="center" rowspan="1" colspan="1">1.79<italic>E &#x02212; </italic>05</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0001573~ganglioside metabolic process</td><td align="center" rowspan="1" colspan="1">2.38<italic>E &#x02212; </italic>05</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0046466~membrane lipid catabolic process</td><td align="center" rowspan="1" colspan="1">1.15<italic>E &#x02212; </italic>04</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0030149~sphingolipid catabolic process</td><td align="center" rowspan="1" colspan="1">1.15<italic>E &#x02212; </italic>04</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0019915~lipid storage</td><td align="center" rowspan="1" colspan="1">1.29<italic>E &#x02212; </italic>04</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0006687~glycosphingolipid metabolic process</td><td align="center" rowspan="1" colspan="1">2.73<italic>E &#x02212; </italic>04</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0006664~glycolipid metabolic process</td><td align="center" rowspan="1" colspan="1">3.90<italic>E &#x02212; </italic>04</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0050885~neuromuscular process controlling balance</td><td align="center" rowspan="1" colspan="1">4.98<italic>E &#x02212; </italic>04</td></tr></tbody></table></table-wrap><table-wrap id="tab5b" orientation="portrait" position="anchor"><caption><p>(b) BvM501</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Cluster number</th><th align="left" rowspan="1" colspan="1">Term</th><th align="center" rowspan="1" colspan="1">
<italic>P</italic> value</th></tr></thead><tbody><tr><td align="left" rowspan="10" colspan="1">1</td><td align="left" rowspan="1" colspan="1">GO:0040008~regulation of growth</td><td align="center" rowspan="1" colspan="1">3.73<italic>E &#x02212; </italic>08</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0051604~protein maturation</td><td align="center" rowspan="1" colspan="1">7.27<italic>E &#x02212; </italic>08</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0001558~regulation of cell growth</td><td align="center" rowspan="1" colspan="1">1.29<italic>E &#x02212; </italic>06</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0016485~protein processing</td><td align="center" rowspan="1" colspan="1">2.32<italic>E &#x02212; </italic>05</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0016044~membrane organization</td><td align="center" rowspan="1" colspan="1">7.38<italic>E &#x02212; </italic>05</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0016064~immunoglobulin mediated immune response</td><td align="center" rowspan="1" colspan="1">9.61<italic>E &#x02212; </italic>05</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0051605~protein maturation by peptide bond cleavage</td><td align="center" rowspan="1" colspan="1">1.09<italic>E &#x02212; </italic>04</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0019724~B cell mediated immunity</td><td align="center" rowspan="1" colspan="1">1.09<italic>E &#x02212; </italic>04</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0002684~positive regulation of immune system process</td><td align="center" rowspan="1" colspan="1">1.29<italic>E &#x02212; </italic>04</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0006958~complement activation, classical pathway</td><td align="center" rowspan="1" colspan="1">2.00<italic>E &#x02212; </italic>04</td></tr><tr><td align="center" colspan="3" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="10" colspan="1">2</td><td align="left" rowspan="1" colspan="1">GO:0009100~glycoprotein metabolic process</td><td align="center" rowspan="1" colspan="1">2.16<italic>E &#x02212; </italic>06</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0050654~chondroitin sulfate proteoglycan metabolic process</td><td align="center" rowspan="1" colspan="1">9.34<italic>E &#x02212; </italic>06</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0006029~proteoglycan metabolic process</td><td align="center" rowspan="1" colspan="1">8.82<italic>E &#x02212; </italic>05</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0048754~branching morphogenesis of a tube</td><td align="center" rowspan="1" colspan="1">1.02<italic>E &#x02212; </italic>04</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0019800~peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan</td><td align="center" rowspan="1" colspan="1">1.89<italic>E &#x02212; </italic>04</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0001763~morphogenesis of a branching structure</td><td align="center" rowspan="1" colspan="1">3.20<italic>E &#x02212; </italic>04</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0001568~blood vessel development</td><td align="center" rowspan="1" colspan="1">4.29<italic>E &#x02212; </italic>04</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0001944~vasculature development</td><td align="center" rowspan="1" colspan="1">4.79<italic>E &#x02212; </italic>04</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0030204~chondroitin sulfate metabolic process</td><td align="center" rowspan="1" colspan="1">6.09<italic>E &#x02212; </italic>04</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0006813~potassium ion transport</td><td align="center" rowspan="1" colspan="1">8.13<italic>E &#x02212; </italic>04</td></tr><tr><td align="center" colspan="3" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="10" colspan="1">3</td><td align="left" rowspan="1" colspan="1">GO:0001501~skeletal system development</td><td align="center" rowspan="1" colspan="1">1.07<italic>E &#x02212; </italic>16</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0030509~BMP signaling pathway</td><td align="center" rowspan="1" colspan="1">6.34<italic>E &#x02212; </italic>14</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0001503~ossification</td><td align="center" rowspan="1" colspan="1">4.02<italic>E &#x02212; </italic>12</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0060348~bone development</td><td align="center" rowspan="1" colspan="1">7.43<italic>E &#x02212; </italic>12</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0030500~regulation of bone mineralization</td><td align="center" rowspan="1" colspan="1">6.08<italic>E &#x02212; </italic>11</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0007178~transmembrane receptor protein serine/threonine kinase signaling pathway</td><td align="center" rowspan="1" colspan="1">7.75<italic>E &#x02212; </italic>11</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0070167~regulation of biomineral formation</td><td align="center" rowspan="1" colspan="1">9.25<italic>E &#x02212; </italic>11</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0007167~enzyme linked receptor protein signaling pathway</td><td align="center" rowspan="1" colspan="1">1.84<italic>E &#x02212; </italic>10</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0007369~gastrulation</td><td align="center" rowspan="1" colspan="1">2.22<italic>E &#x02212; </italic>10</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0051216~cartilage development</td><td align="center" rowspan="1" colspan="1">3.31<italic>E &#x02212; </italic>10</td></tr><tr><td align="center" colspan="3" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="10" colspan="1">4</td><td align="left" rowspan="1" colspan="1">GO:0006928~cell motion</td><td align="center" rowspan="1" colspan="1">9.88<italic>E &#x02212; </italic>05</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0016055~Wnt receptor signaling pathway</td><td align="center" rowspan="1" colspan="1">2.59<italic>E &#x02212; </italic>04</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0016477~cell migration</td><td align="center" rowspan="1" colspan="1">4.37<italic>E &#x02212; </italic>04</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0048870~cell motility</td><td align="center" rowspan="1" colspan="1">7.09<italic>E &#x02212; </italic>04</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0051674~localization of cell</td><td align="center" rowspan="1" colspan="1">7.09<italic>E &#x02212; </italic>04</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0007160~cell-matrix adhesion</td><td align="center" rowspan="1" colspan="1">0.001189285</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0009100~glycoprotein metabolic process</td><td align="center" rowspan="1" colspan="1">0.001250564</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0031589~cell-substrate adhesion</td><td align="center" rowspan="1" colspan="1">0.001570006</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0007155~cell adhesion</td><td align="center" rowspan="1" colspan="1">0.005368157</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0022610~biological adhesion</td><td align="center" rowspan="1" colspan="1">0.005405426</td></tr><tr><td align="center" colspan="3" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="10" colspan="1">5</td><td align="left" rowspan="1" colspan="1">GO:0006689~ganglioside catabolic process</td><td align="center" rowspan="1" colspan="1">1.66<italic>E &#x02212; </italic>05</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0019377~glycolipid catabolic process</td><td align="center" rowspan="1" colspan="1">5.78<italic>E &#x02212; </italic>05</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0046479~glycosphingolipid catabolic process</td><td align="center" rowspan="1" colspan="1">5.78<italic>E &#x02212; </italic>05</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0001573~ganglioside metabolic process</td><td align="center" rowspan="1" colspan="1">7.69<italic>E &#x02212; </italic>05</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0009611~response to wounding</td><td align="center" rowspan="1" colspan="1">2.01<italic>E &#x02212; </italic>04</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0046466~membrane lipid catabolic process</td><td align="center" rowspan="1" colspan="1">3.70<italic>E &#x02212; </italic>04</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0030149~sphingolipid catabolic process</td><td align="center" rowspan="1" colspan="1">3.70<italic>E &#x02212; </italic>04</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0019915~lipid storage</td><td align="center" rowspan="1" colspan="1">4.16<italic>E &#x02212; </italic>04</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0006687~glycosphingolipid metabolic process</td><td align="center" rowspan="1" colspan="1">8.77<italic>E &#x02212; </italic>04</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0009311~oligosaccharide metabolic process</td><td align="center" rowspan="1" colspan="1">0.001247784</td></tr><tr><td align="center" colspan="3" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="10" colspan="1">6</td><td align="left" rowspan="1" colspan="1">GO:0042592~homeostatic process</td><td align="center" rowspan="1" colspan="1">6.03<italic>E &#x02212; </italic>06</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0043270~positive regulation of ion transport</td><td align="center" rowspan="1" colspan="1">0.001725638</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0051270~regulation of cell motion</td><td align="center" rowspan="1" colspan="1">0.002725255</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0048771~tissue remodeling</td><td align="center" rowspan="1" colspan="1">0.003048492</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0001894~tissue homeostasis</td><td align="center" rowspan="1" colspan="1">0.003842174</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0051050~positive regulation of transport</td><td align="center" rowspan="1" colspan="1">0.004095371</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway</td><td align="center" rowspan="1" colspan="1">0.004147057</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0032869~cellular response to insulin stimulus</td><td align="center" rowspan="1" colspan="1">0.004461779</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0042127~regulation of cell proliferation</td><td align="center" rowspan="1" colspan="1">0.004903945</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0010765~positive regulation of sodium ion transport</td><td align="center" rowspan="1" colspan="1">0.005901212</td></tr><tr><td align="center" colspan="3" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="9" colspan="1">7</td><td align="left" rowspan="1" colspan="1">GO:0001666~response to hypoxia</td><td align="center" rowspan="1" colspan="1">0.006023043</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0070482~response to oxygen levels</td><td align="center" rowspan="1" colspan="1">0.006648281</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0016042~lipid catabolic process</td><td align="center" rowspan="1" colspan="1">0.009864913</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0006644~phospholipid metabolic process</td><td align="center" rowspan="1" colspan="1">0.011805904</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0019637~organophosphate metabolic process</td><td align="center" rowspan="1" colspan="1">0.013020542</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0006916~anti-apoptosis</td><td align="center" rowspan="1" colspan="1">0.013774773</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0043066~negative regulation of apoptosis</td><td align="center" rowspan="1" colspan="1">0.037899056</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0043069~negative regulation of programmed cell death</td><td align="center" rowspan="1" colspan="1">0.038883095</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0060548~negative regulation of cell death</td><td align="center" rowspan="1" colspan="1">0.03908111</td></tr><tr><td align="center" colspan="3" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" colspan="3" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="11" colspan="1">9</td><td align="left" rowspan="1" colspan="1">GO:0007160~cell-matrix adhesion</td><td align="center" rowspan="1" colspan="1">0.001495186</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0031589~cell-substrate adhesion</td><td align="center" rowspan="1" colspan="1">0.001809131</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0051085~chaperone mediated protein folding requiring cofactor</td><td align="center" rowspan="1" colspan="1">0.006635187</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0051084~&#x0201c;de novo&#x0201d; posttranslational protein folding</td><td align="center" rowspan="1" colspan="1">0.008618097</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0007155~cell adhesion</td><td align="center" rowspan="1" colspan="1">0.00916406</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0022610~biological adhesion</td><td align="center" rowspan="1" colspan="1">0.009200307</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0050982~detection of mechanical stimulus</td><td align="center" rowspan="1" colspan="1">0.010597488</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0006458~&#x0201c;de novo&#x0201d; protein folding</td><td align="center" rowspan="1" colspan="1">0.010597488</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0007259~JAK-STAT cascade</td><td align="center" rowspan="1" colspan="1">0.025656487</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0030001~metal ion transport</td><td align="center" rowspan="1" colspan="1">0.036163834</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0030001~metal ion transport</td><td align="center" rowspan="1" colspan="1">0.036163834</td></tr></tbody></table></table-wrap><table-wrap id="tab5c" orientation="portrait" position="anchor"><caption><p>(c) LvM442</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Cluster number</th><th align="left" rowspan="1" colspan="1">Term</th><th align="center" rowspan="1" colspan="1">
<italic>P</italic> value</th></tr></thead><tbody><tr><td align="left" rowspan="10" colspan="1">1</td><td align="left" rowspan="1" colspan="1">GO:0001568~blood vessel development</td><td align="center" rowspan="1" colspan="1">1.06<italic>E &#x02212; </italic>18</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0001944~vasculature development</td><td align="center" rowspan="1" colspan="1">1.64<italic>E &#x02212; </italic>18</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0048514~blood vessel morphogenesis</td><td align="center" rowspan="1" colspan="1">8.45<italic>E &#x02212; </italic>16</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0001525~angiogenesis</td><td align="center" rowspan="1" colspan="1">3.48<italic>E &#x02212; </italic>12</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0048754~branching morphogenesis of a tube</td><td align="center" rowspan="1" colspan="1">9.17<italic>E &#x02212; </italic>11</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0007167~enzyme linked receptor protein signaling pathway</td><td align="center" rowspan="1" colspan="1">5.50<italic>E &#x02212; </italic>10</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0035239~tube morphogenesis</td><td align="center" rowspan="1" colspan="1">1.14<italic>E &#x02212; </italic>09</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0001763~morphogenesis of a branching structure</td><td align="center" rowspan="1" colspan="1">1.32<italic>E &#x02212; </italic>09</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0035295~tube development</td><td align="center" rowspan="1" colspan="1">5.53<italic>E &#x02212; </italic>09</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0001569~patterning of blood vessels</td><td align="center" rowspan="1" colspan="1">3.29<italic>E &#x02212; </italic>08</td></tr><tr><td align="center" colspan="3" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="10" colspan="1">2</td><td align="left" rowspan="1" colspan="1">GO:0040008~regulation of growth</td><td align="center" rowspan="1" colspan="1">4.27<italic>E &#x02212; </italic>07</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0009611~response to wounding</td><td align="center" rowspan="1" colspan="1">4.18<italic>E &#x02212; </italic>06</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0006954~inflammatory response</td><td align="center" rowspan="1" colspan="1">3.42<italic>E &#x02212; </italic>05</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0032101~regulation of response to external stimulus</td><td align="center" rowspan="1" colspan="1">1.89<italic>E &#x02212; </italic>04</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0048585~negative regulation of response to stimulus</td><td align="center" rowspan="1" colspan="1">7.82<italic>E &#x02212; </italic>04</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0006952~defense response</td><td align="center" rowspan="1" colspan="1">0.001399518</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0001558~regulation of cell growth</td><td align="center" rowspan="1" colspan="1">0.002134607</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0050867~positive regulation of cell activation</td><td align="center" rowspan="1" colspan="1">0.002784166</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0032102~negative regulation of response to external stimulus</td><td align="center" rowspan="1" colspan="1">0.004518678</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0008283~cell proliferation</td><td align="center" rowspan="1" colspan="1">0.004842417</td></tr><tr><td align="center" colspan="3" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="10" colspan="1">3</td><td align="left" rowspan="1" colspan="1">GO:0007160~cell-matrix adhesion</td><td align="center" rowspan="1" colspan="1">7.84<italic>E &#x02212; </italic>05</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0031589~cell-substrate adhesion</td><td align="center" rowspan="1" colspan="1">1.14<italic>E &#x02212; </italic>04</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0044242~cellular lipid catabolic process</td><td align="center" rowspan="1" colspan="1">9.80<italic>E &#x02212; </italic>04</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0016042~lipid catabolic process</td><td align="center" rowspan="1" colspan="1">9.93<italic>E &#x02212; </italic>04</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0051346~negative regulation of hydrolase activity</td><td align="center" rowspan="1" colspan="1">0.006807864</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0008218~bioluminescence</td><td align="center" rowspan="1" colspan="1">0.007742186</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0018401~peptidyl-proline hydroxylation to 4-hydroxy-L-proline</td><td align="center" rowspan="1" colspan="1">0.007742186</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0019471~4-hydroxyproline metabolic process</td><td align="center" rowspan="1" colspan="1">0.007742186</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0009101~glycoprotein biosynthetic process</td><td align="center" rowspan="1" colspan="1">0.007780584</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0007155~cell adhesion</td><td align="center" rowspan="1" colspan="1">0.00843311</td></tr><tr><td align="center" colspan="3" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="8" colspan="1">4</td><td align="left" rowspan="1" colspan="1">GO:0001501~skeletal system development</td><td align="center" rowspan="1" colspan="1">7.15<italic>E &#x02212; </italic>04</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0006955~immune response</td><td align="center" rowspan="1" colspan="1">0.011579</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0051085~chaperone mediated protein folding requiring cofactor</td><td align="center" rowspan="1" colspan="1">0.013230724</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0051084~&#x0201c;de novo&#x0201d; posttranslational protein folding</td><td align="center" rowspan="1" colspan="1">0.01716759</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0045453~bone resorption</td><td align="center" rowspan="1" colspan="1">0.019783921</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0006458~&#x0201c;de novo&#x0201d; protein folding</td><td align="center" rowspan="1" colspan="1">0.021089619</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0046849~bone remodeling</td><td align="center" rowspan="1" colspan="1">0.027593503</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0006952~defense response</td><td align="center" rowspan="1" colspan="1">0.045862312</td></tr><tr><td align="center" colspan="3" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="10" colspan="1">5</td><td align="left" rowspan="1" colspan="1">GO:0001916~positive regulation of T cell mediated cytotoxicity</td><td align="center" rowspan="1" colspan="1">4.08<italic>E &#x02212; </italic>05</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0001914~regulation of T cell mediated cytotoxicity</td><td align="center" rowspan="1" colspan="1">6.22<italic>E &#x02212; </italic>05</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0002711~positive regulation of T cell mediated immunity</td><td align="center" rowspan="1" colspan="1">8.81<italic>E &#x02212; </italic>05</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0002474~antigen processing and presentation of peptide antigen via MHC class I</td><td align="center" rowspan="1" colspan="1">1.53<italic>E &#x02212; </italic>04</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0002709~regulation of T cell mediated immunity</td><td align="center" rowspan="1" colspan="1">1.72<italic>E &#x02212; </italic>04</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0031343~positive regulation of cell killing</td><td align="center" rowspan="1" colspan="1">2.84<italic>E &#x02212; </italic>04</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0001912~positive regulation of leukocyte mediated cytotoxicity</td><td align="center" rowspan="1" colspan="1">2.84<italic>E &#x02212; </italic>04</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0001910~regulation of leukocyte mediated cytotoxicity</td><td align="center" rowspan="1" colspan="1">4.86<italic>E &#x02212; </italic>04</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0031341~regulation of cell killing</td><td align="center" rowspan="1" colspan="1">4.86<italic>E &#x02212; </italic>04</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0002821~positive regulation of adaptive immune response</td><td align="center" rowspan="1" colspan="1">6.25<italic>E &#x02212; </italic>04</td></tr><tr><td align="center" colspan="3" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="10" colspan="1">6</td><td align="left" rowspan="1" colspan="1">GO:0002526~acute inflammatory response</td><td align="center" rowspan="1" colspan="1">4.67<italic>E &#x02212; </italic>14</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0045087~innate immune response</td><td align="center" rowspan="1" colspan="1">4.65<italic>E &#x02212; </italic>13</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0002684~positive regulation of immune system process</td><td align="center" rowspan="1" colspan="1">1.53<italic>E &#x02212; </italic>12</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0050778~positive regulation of immune response</td><td align="center" rowspan="1" colspan="1">3.29<italic>E &#x02212; </italic>12</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0006954~inflammatory response</td><td align="center" rowspan="1" colspan="1">3.41<italic>E &#x02212; </italic>12</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0002541~activation of plasma proteins involved in acute inflammatory response</td><td align="center" rowspan="1" colspan="1">4.05<italic>E &#x02212; </italic>12</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0006956~complement activation</td><td align="center" rowspan="1" colspan="1">4.05<italic>E &#x02212; </italic>12</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0048584~positive regulation of response to stimulus</td><td align="center" rowspan="1" colspan="1">4.13<italic>E &#x02212; </italic>11</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0006952~defense response</td><td align="center" rowspan="1" colspan="1">4.75<italic>E &#x02212; </italic>11</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0006959~humoral immune response</td><td align="center" rowspan="1" colspan="1">5.29<italic>E &#x02212; </italic>11</td></tr><tr><td align="center" colspan="3" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="10" colspan="1">7</td><td align="left" rowspan="1" colspan="1">GO:0009611~response to wounding</td><td align="center" rowspan="1" colspan="1">2.97<italic>E &#x02212; </italic>06</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0006958~complement activation, classical pathway</td><td align="center" rowspan="1" colspan="1">7.07<italic>E &#x02212; </italic>06</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0002526~acute inflammatory response</td><td align="center" rowspan="1" colspan="1">7.33<italic>E &#x02212; </italic>06</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0002455~humoral immune response mediated by circulating immunoglobulin</td><td align="center" rowspan="1" colspan="1">8.69<italic>E &#x02212; </italic>06</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0006956~complement activation</td><td align="center" rowspan="1" colspan="1">2.20<italic>E &#x02212; </italic>05</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0002541~activation of plasma proteins involved in acute inflammatory response</td><td align="center" rowspan="1" colspan="1">2.36<italic>E &#x02212; </italic>05</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0016064~immunoglobulin mediated immune response</td><td align="center" rowspan="1" colspan="1">4.70<italic>E &#x02212; </italic>05</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0019724~B cell mediated immunity</td><td align="center" rowspan="1" colspan="1">5.25<italic>E &#x02212; </italic>05</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0002449~lymphocyte mediated immunity</td><td align="center" rowspan="1" colspan="1">1.02<italic>E &#x02212; </italic>04</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0002250~adaptive immune response</td><td align="center" rowspan="1" colspan="1">1.36<italic>E &#x02212; </italic>04</td></tr><tr><td align="center" colspan="3" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="9" colspan="1">8</td><td align="left" rowspan="1" colspan="1">GO:0051450~myoblast proliferation</td><td align="center" rowspan="1" colspan="1">0.002206368</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0048012~hepatocyte growth factor receptor signaling pathway</td><td align="center" rowspan="1" colspan="1">0.002206368</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0060665~regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling</td><td align="center" rowspan="1" colspan="1">0.003674845</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0060638~mesenchymal-epithelial cell signaling</td><td align="center" rowspan="1" colspan="1">0.004408354</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0060693~regulation of branching involved in salivary gland morphogenesis</td><td align="center" rowspan="1" colspan="1">0.006605966</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0060688~regulation of morphogenesis of a branching structure</td><td align="center" rowspan="1" colspan="1">0.018252999</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0001889~liver development</td><td align="center" rowspan="1" colspan="1">0.031208893</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0000187~activation of MAPK activity</td><td align="center" rowspan="1" colspan="1">0.036205594</td></tr><tr><td align="left" rowspan="1" colspan="1">GO:0043406~positive regulation of MAP kinase activity</td><td align="center" rowspan="1" colspan="1">0.042595839</td></tr></tbody></table></table-wrap></table-wrap-group></floats-group></article>